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ABSTRACT 
Aflatoxin Bi (AFBi), a highly toxic fungal metabolite (mycotoxin) of certain strains of 
Aspergillus, has long been known to be carcinogenic in animal species. Accumulation of 
epidemiological evidence led to its classification, in 1993, by the International Agency for Research 
on Cancer as a Group I human carcinogen. Aflatoxin Bi contaminates the food supply in most 
tropical and sub-tropical countries, where it is associated with increased incidence of hepatocellular 
carcinoma (HCC). In these countries, AFBi is also linked to kwashiorkor, jaundice, and Rey's 
syndrome. The biological action of AFBi is through its oxidation to AFBi-8,9 epoxide (AFBiO). 
This epoxide binds to macromolecules like DNA, RNA and proteins as well as amino acids to form 
AFBi-macromolecular adducts. Quantitation of these adducts is thought to be the most promising 
approach in the development of methods to measure levels of exposure to aflatoxins. 
Aflatoxin Bi was produced, isolated and purified using preparative thin layer 
chromatography (TLC). The toxin was oxidised to AFBiO using dimethyldioxirane and the UV 
spectra of both the AFBi and AFBiO were determined. Reaction of selected Na-acetyl amino acids 
(AA) with AFBiO was studied and UV spectrophotometry, TLC, high performance liquid 
chromatography (FfPLC) and high performance capillary electrophoresis (CE) were used to 
characterise the reaction products. The epoxide was also reacted with albumin and DNA. Aflatoxin 
Bi-albumin reaction mixture was hydrolysed and characterised by TLC. 
Spectrum measurement of the oxidative product of AFBi gave peaks at 266 and 367nm. 
Qualitative TLC and the epoxide spray reagents confirmed that epoxidation was successful. The in 
vivo reaction of selected Na-acetyl AA with the epoxide gave peaks between 300 and 400 nm. Na-
acetyl-arginine, Na-acetyl-lysine and Na-acetyl-histidine showed reaction with AFBiO with 
maximum wavelengths at 392, 397 and 391 nm respectively. These results strongly suggest that 
AFBiO is able to covalently bind to lysine, histidine and arginine in albumin. 
A total of twenty nine blood samples were analysed by HPLC for the presence of AFBi-
lysyl adduct. Of the twenty nine samples, ten were from HCC patients, ten from control patients 
and nine from kwashiorkor patients. The results show that AFBi-lysine does occur in patients at 
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CHAPTER 1 
GENERAL INTRODUCTION AND OBJECTIVES 
The role of mycotoxins in the well being of man is increasingly receiving attention, because of 
its negative impact on human nutrition and health (Smith et al, 1995). In KwaZulu-Natal, South 
Africa, mycotoxins have been found to occur in cereals and animal feedstuffs (Dutton and Westlake 
1985; Dutton and Kinsey, 1995). These surveys are consistent with the evidence from different studies 
that many foods, which are commonly eaten in the tropics and subtropics, e.g., ground nuts, maize, 
sorghum, rice etc., are contaminated by fungi which produce mycotoxins (Goldblatt, 1969; Nwokolo 
and Okonkwo, 1978). Furthermore, general screening of home-grown maize and other foodstuffs in 
South Africa revealed the frequent presence of the mycotoxins: deoxynivalenol, fumonisins, 
zearalenone and aflatoxins (Dutton et al, 1993). 
Studies from other parts of the world have shown that about 1.4 - 2.3% of ingested aflatoxin 
Bi (AFBi) becomes covalently bound to serum albumin (Gan et al, 1988). These protein conjugates 
can be detected by chromatographic assays. Measurements of aflatoxin bound to serum albumin in 
children and adults from various countries show that between 12 and 100% of them contain aflatoxin-
albumin adducts, with levels up to 350pg AFBi-lysine equivalent/mg albumin (Wild et al, 1990a). 
Members of the population in the greater Durban area, South Africa, may be exposed to dietary 
aflatoxins (Ramjee et al, 1992), which is worrying because AFBi is now well known to be a human 
carcinogen (IARC, 1993). 
Cancer is among the most feared diseases in the modern industrialised world and it is often a 
progressive fatal condition. It is one of the three leading causes of death in most countries. An 
estimated 80 - 90% of human cancer is linked to "extrinsic" or environmental factors, and its incidence 
could be minimised if the causative extrinsic factors could be identified and humans protected from 
them (Doll and Peto, 1981). This can either be achieved by elimination of exposure or by reduction of 
the host susceptibility. Diet presents a major source of human exposure to environmental carcinogens 
and epidemiological analyses indicate that 20 - 50% of all human cancer is associated with dietary 
factors (Wynder and Gori, 1977; Doll and Peto, 1981). Cancer usually delays for ten or more years 
after exposure to a chemical carcinogen and therefore retrospective epidemiological studies are 
difficult. Scientists have developed sensitive methods that quantitate an individual low-level 
environmental exposure to a particular carcinogen. These methods can produce data that may 
establish a causal relationship between an agent and cancer (Chang et ah, 1994). 
This project reports on a screening programme on people in Durban, South Africa. Aflatoxin 
Bi was selected because of its high toxicity and carcinogenicity and also because of its high prevalence 
in South Africa. The basis for this project is that humans exposed to AFBi form conjugates of DNA 
and blood proteins through the epoxide of AFBi, generated in the liver. These conjugates may be 
detected by suitable digestion and chromatography of the monomer-AFBi, either lysyl-AFBi or 
guanyl-AFBi depending upon the source. Levels of these conjugates are proportional to the history of 
exposure of the subject to aflatoxin in the diet. 
The objectives of this study were therefore to> 
* synthesise AFBi-macromolecular conjugates 
* develop chromatography methods for detection and routine screening of AFBi-
macromolecular conjugates 
* determine which amino acids bind to AFBi 
* analyse human blood samples for the presence of AFBi-lysine and other conjugates. 
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CHAPTER 2 
LITERATURE SURVEY ^Jb^v 
2.1 MYCOTOXINS AND SECONDARY METABOLISM 
Mycotoxins are mould secondary metabolites which, following consumption through 
contaminated food or feed, cause illness or death of man and animals (Smith and Moss, 1985). Disease 
caused by mycotoxins, which may be chronic or acute, is referred to as a mycotoxicosis. 
Generalities which can be made about mycotoxins are:-
* The major number of known mycotoxins are produced by a few genera of moulds, including 
Aspergillus, Penicillium and Fusarium species. 
* Many arise through the polyketide biosynthetic pathway. 
* The liver is frequently the primary target organ in mammals, reflecting its detoxification 
function. 
Secondary metabolites are natural products of incredible chemical diversity, obscure function 
and restricted taxonomic distribution that occur in chemical clusters or families. They usually require a 
narrower range of trace metal, pH and temperature for their production than is needed for the growth 
of the producing organism. They are normally synthesised after active growth has stopped, during the 
idiophase of the fungal life cycle (Bennett, 1985). Several propositions on the role of secondary 
metabolism centre on the suggestion that it is the process of secondary metabolism, not the secondary 
metabolites themselves, which are of importance to the organism (Haslam, 1985). An early idea 
concerning the function of secondary metabolism, was that advanced by Woodruff in 1966 (Weinberg, 
1971) who envisaged secondary metabolism as an overflow process resulting from unbalanced growth 
and secondary metabolites as shunt metabolites, produced in order to reduce abnormal concentrations 
of normal intermediates. This theory has been modified by others and it has been suggested that 
secondary metabolism is a means of detoxification. When normal intermediates in metabolism reach 
concentrations toxic to the producing cell, the organism responds by diversion of the intermediate to a 
less metabolically active secondary product, which may be expelled into the environment or secreted in 
the cell. The third idea is that secondary metabolites are merely waste products of metabolism in 
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phylogenetically less advanced organisms. Bu'Lock (1980) has speculated that secondary metabolism 
serves to maintain basic metabolism in circumstances when its normal substrates, through nutritional 
imbalances and depletions, cannot be exploited for normal cellular growth and replication. There are a 
number of differences between primary metabolites and secondary metabolites viz., :-
Primary metabolites: 
* They are widely distributed in nature. 
* They are present during most of the life cycle of the organism. 
* They have well defined physiological roles and are essential for growth. 
* Examples include amino acids, lipids, nucleic acids, intermediates of citric acid cycle, and other 
such intermediary metabolites. 
Secondary metabolites: 
* They are of restricted taxonomic distribution. 
* They are usually produced at only one stage of the life cycle. 
i 
* They have obscure biological function. 
* Unlike primary metabolites, secondary metabolites are not essential for growth. 
* Examples of secondary metabolites are toxins and antibiotics (Bennett, 1985). 
Mycotoxins exhibit a wide array of biological effects because of the diversity of their chemical 
structures. Individual mycotoxins can be: mutagenic e.g., AFBi, sterigmatocystin, citrinin, 
zearalenone, penicillic acid and patulin; carcinogenic e.g., aflatoxins, sterigmatocystin, penicillic acid, 
patulin, luteoskyrin, rugulosin, citrinin and ochratoxin A; teratogenic e.g., AFBi, ochratoxin A, 
rubratoxin B, T-2 toxin and certain ergot alkaloids; and oestrogenic e.g., zearalenone (Smith and 
Moss, 1985; Steyn and Vleggaar, 1986). 
Mycotoxins have also been classified according to the specific organs and tissues they primarily 
damage (Hayes, 1981; Smith and Moss, 1985), i.e.,: hepatotoxins, e.g., AFBi and ochratoxin A; 
nephrotoxins, e.g., ochratoxin A, citrinin, AFBi, rubratoxin B and sterigmatocystin; neurotoxins e.g., 
citreoviridin and patulin; dermatoxins e.g., trichothecens, T-2 toxin, diacetoxyscipenol, and 
sporodesmins. 
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Mycotoxins affect the basic metabolic processes such as carbohydrate metabolism, 
mitochondrial function, lipid metabolism, and the biosynthesis of proteins and nucleic acids. The four 
mechanisms causing these effects are:-
* inhibiting key enzymes, 
* reacting with DNA and RNA to inhibit protein synthesis, 
* interacting with biological membranes, and 
* reacting with enzyme cofactors (Keeler, et ah, 1992). 
In the early 1940s and 1950s research on fungal metabolism was mainly concerned with the 
discovery of new antibiotics. During this time, although several mycotoxins were first discovered, they 
were systematically disregarded. Interest grew in antibiotics because of their health and commercial 
benefit, whereas mycotoxins were not considered useful because of their toxic properties (Bennett, 
1985). Consequently no attention was paid to the implied threat to human and animal health by 
mycotoxins, and mycotoxicosis has been referred to as "the neglected disease" (Forgacs, 1962; Forgacs 
and Carll, 1962). 
In 1960 a "poultry disease, "Turkey X" disease, which killed over 100 000 turkey poults in the 
United Kingdom was traced to mould-contaminated feedstuffs (Goldblatt, 1969). This triggered new 
interest in the study of mycotoxin and ultimately led to the subsequent identification of over 250 toxic 
fungal metabolites. The etiological agent responsible for "Turkey X" disease was associated with the 
mould contamination of Brazilian groundnut meal and shown to be the aflatoxins (Allcroft and 
Carnaghan, 1962). These were later also identified as potent naturally occurring carcinogens 
(Goldblatt, 1969). Later it was discovered that cyclopiazonic acid was also involved in "Turkey X" 
disease (Cole, 1986) and consequently this condition is the first example of a multi-mycotoxicosis. 
2.2 AFLATOXINS L| ( )^ r ••\ciditAV+ u ( w M o . 
Aflatoxins are toxic metabolites produced by moulds widely encountered in most parts of the 
world (McLellan et al, 1994) and are produced by some strains of Aspergillus flavus, A. nomius and 
A. parasiticus (Chu and Ueno, 1977; Hesseltine, 1986). The name aflatoxins is derived from 
Aspergillus flaxnis toxins. They are a major problem facing feed and food producers (Conning and 
Lansdown, 1983), particularly in third world countries because, while attempting to alleviate 
malnutrition in such population, individuals may suffer severe liver and other injury. This is the case 
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because important protein sources such as peanuts and cereals, especially maize may be contaminated 
by mycotoxin-producing fungi. 
Aflatoxins are among the most common fungal contaminants of agricultural commodities in 
tropical and sub-tropical areas, where the warmth and humidity provide optimal conditions for their 
growth. The general life cycle of aflatoxin-producing fungi is shown in Fig. 2.1 Spores infect the seed 
in the field where they germinate, penetrate the seed coat and produce toxin inside the seed (Keeler et 
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Figure 2.1 General life cycle ofAspergillus flavus, a mycotoxin-producing fungi. Aspergillus flavus can 
produce aflatoxins on maize in the field, after harvest, in storage or during processing of foods 
(Keeler et al, 1992). 
The ingestion of aflatoxins by animals results in acute liver toxicity and hepatoma 
(Coulter, 1987). Researchers have been able to elucidate a family of related aflatoxin compounds. 
These compounds share the common structural features of a bisfuran ring system fused to a substituted 
coumarin nucleus, (Fig. 2.2). The major aflatoxins (AFs) are aflatoxin Bi (AFBi), aflatoxin B2 (AFB2), 
aflatoxin Gi (AFGi), and aflatoxin G2 (AFG2) as shown in Fig. 2.2. They were given these names 
because of their respective blue and green fluorescence under long-wave ultra-violet (UV) light, and 
their chromatographic mobilities. 
e> 
AFB, AFB2 
Figure 2.2 Chemical structures of Anatoxins (AFs) B], AFB2, AFGi, and AFG2 (Eaton and 
Gallagher, 1994). 
Aflatoxin Bi is an extremely potent carcinogen. In rats, it is one of the most active 
hepatocarcinogens known. Not only is AFBi the most potent hepatocarcinogen of the aflatoxins, but it 
is the most abundant commodity (Goldblatt, 1969). For these reasons, most research has concentrated 
on AFBi. 
Aflatoxin Bi has been classified by the International Agency for Research on Cancer (IARC) as 
a Group I human carcinogen (Autrup et ah, 1991); and one of its metabolic products found in milk, 
AFMi, as a Group 2B possible human carcinogen, (IARC, 1993). This spells the potential dangers of 
aflatoxins to the well-being of man. 
2.3 FACTORS AFFECTING PRODUCTION OF AFLATOXINS IN NATURAL 
SUBSTRATES 
The most important factors affecting the development of aflatoxin concentration are the 
fungus, the substrate, temperature and moisture (Schroeder, 1969). 
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2.3.1 Fungus 
The A. flavus group of fungal species includes: A. flavus and A. parasiticus, which produce 
anatoxin, as well as A. oryzae and A. tamarii, which do not (Goldblatt 1969). The type of aflatoxin 
produced in vitro by isolates of A. flavus and A. parasiticus vary widely, depending on natural 
substrates. Aspergillus parasiticus is reported to produce both the B and the G aflatoxins whereas A. 
flavus produces the Bs only (Klich and Pitt, 1988). 
2.3.2 The Substrate 
Early investigators reported relatively low yields of aflatoxins with chemically defined media. 
Natural materials were, therefore, evaluated as suitable substrates for producing large quantities of 
aflatoxin with fewest interfering substances. Natural substrates are typically moistened with water, 
sterilised, inoculated, and incubated at 25 - 30°C for 5 to 14 days. 
2.3.3 Relative Humidity and Moisture 
The most important factor in growth and aflatoxin production by A. flavus is the moisture 
content of or relative humidity (RH) of a natural substrate. A temperature range of 25 to 35°C and 
moisture contents at adsorption equilibrium with relative humidities of 80 to 100 % are favourable for 
the production and accumulation of the toxin in stored field crops (Schroeder, 1969). At 70% RH 
very few fungi will grow, this is the safe storage moisture content equivalent for seeds and other 
natural substrates (Goldblatt 1969). Aspergillus flavus is a mesophyte with a minimum of 80% RH 
for growth and 85% RH for sporulation (Goldblatt, 1969). 
2.3.4 Temperature and Time 
Temperature is one of the most important environmental factors influencing the growth and 
toxin production of toxigenic fungi. Boiler and Schroeder (1973) observed that at 30°C, invasion and 
colonisation of rice inoculated with A. parasiticus increased with storage humidity. At relative 
humidity (RH) of 70, 75, and 80%, 15 to 30% of the kernels were infected. More rapid invasion and 
colonisation by A. parasiticus, greater accumulations of aflatoxins, and greater activity by species of 
the natural mycoftora accompanied increases in the storage RH. Diener and Davis (1970) studied the 
limiting temperature and relative humidity for aflatoxin production by Aspergillus flavus in stored 
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peanuts, and found that aflatoxin was formed in sound mature kernels between 40°C and 14°C and in 
broken kernels down to 13°C, but none was formed at 41°C after days or at 12°C after 84 days in 98± 
1% RH. The limiting temperatures for aflatoxin formation in peanut kernels with intact shell were 
41°C for 21 days and 16°C for 84 days of incubation. It was found that the limiting RH at 30°C for 
aflatoxin production in sound mature kernels was 84%, in broken mature kernels and immature kernels 
limiting RH was 83% and in kernels from unshelled peanuts it was 86% for 84 days of incubation. The 
limiting RH at 20°C for sound and broken mature kernels was 83%, 86% for immature kernels and 
92% for kernels from unshelled peanuts. 
The cycling of temperature between 33°C and 15°C has been found to favour AFBi 
accumulation, whereas cycling between 25°C and 15°C favours AFGi production. This could possibly 
be explained through the control of the enzyme systems responsible for relative production of AFB i 
and AFG2 (Lin et ai, 1980). Schroeder and Hein (1967) also found that more AFG was produced or 
accumulated in relation to AFB at low temperatures (within optimal range). Maximal production of 
aflatoxin occurred at 24°C and maximal growth oiA.flavus isolates occurred between 29°C and 35°C. 
The yellow colour of chloroform extracts appeared to be directly correlated with aflatoxin 
concentration (Schindler et ah, 1967). Recent work by Karunaratne and Bullerman (1990) has 
indicated that it is possible that the faster growing mycelia at 35°C are capable of breaking down the 
preformed aflatoxin and this has an important implication on the detoxification process of aflatoxins. 
2.4 METABOLISM AND BIOCHEMICAL EFFECTS OF AFLATOXIN Bi 
METABOLISM 
Chemical methods based primarily upon their fluorescence properties have been applied to 
study the metabolism of aflatoxin by living systems. 
2.4.1 Toxic Metabolites in Milk 
In some early investigations, animals were fed with toxic rations to investigate the metabolic 
fate of aflatoxins. Allcroft and Carnaghan (1963) reported that cows fed with toxin contaminated 
peanut meals excreted in their milk, a factor that was toxic to ducklings. Methanol-chloroform extracts 
of the milk were administered to ducklings and caused liver lesions or death. The liver lesions were 
similar to those caused by authentic samples of aflatoxins. 
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In further studies it was found that the toxic principle was only in the rennet-precipitated casein 
fraction of the milk. De long et al. (1964) demonstrated the presence of "milk toxin" in the milk of 
lactating rats treated with chromatographically pure AFBi. They concluded that the toxic principle in 
milk represented a metabolic product of AFBi that retained the toxic properties of the parent 
compound and this was called AFMi. 
Aflatoxin mixtures were administered to animals and the compounds themselves or derivatives 
of them appeared in urine, faeces and milk. Only small proportions of the compounds administered 
were excreted without metabolic conversion to derivative form. Some of the metabolic conversions of 
AFBi are:-
* hydroxylation of the bis-furan ring which gives rise to the monohydroxylated derivative AFMi 
(Figure 2.3); this has been found in milk and livers of several animal species. Recently it has been 
shown that AFMi, like AFBi, also forms epoxides (Bujons et al, 1995) and this is suspected to be 
responsible for its possible carcinogenicity. 
* o-demethylation, a major degradative pathway in the rat, which gives rise to a phenolic derivative 
whose subsequent metabolic fate is unknown. 
These processes take place principally in the liver of treated animals, this is a fact related to the 
retention of the compound by that organ and also to the localisation of histological and biochemical 
effects of the compound in that tissue. Less is known about the metabolic fates of AFB2, AFGi, and 
AFG2, but they probably undergo similar changes. 
0H 1 jLJ riba 
O O OCH3 
AFM, 
Figure 2.3 Chemical structure of aflatoxin Mi (Van Egmond, 1989). 
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2.4.2 Metabolic Effects Of Anatoxins /^HiUWx 
The most potent member of the aflatoxin series with regard to toxicity to animals, is AFBi. 
Biochemical changes occurring immediately after exposure of animal and cell cultures to aflatoxins 
have revealed a general pattern of responses (Cray and Wogan, 1981) which, because of their early 
and consistent occurrence and their central position in certain cellular metabolic pathways, are thought 
to play an important role in the toxicity of the compound. Responses involved in these exposures 
concern alterations induced by aflatoxins in nucleic acid and protein metabolism. 
The following is an outlined sequence of events in which aflatoxins interfere with nucleic acid 
and protein metabolism:-
* interaction of aflatoxin(s) with DNA (an initial critical event in the sequence) 
* interaction interferes with DNA transcription, 
* failure of DNA transcription results in impairment of both DNA and RNA synthesis (inhibition 
of the polymerases responsible for the respective synthesis), 
* inhibition of protein synthesis. 
All of these responses have been observed in one or more in vivo experimental systems in 
which animals were exposed to effective doses of AFBi, and several have also been demonstrated with 
in vitro cell cultures. 
2.4.3 Interaction of AFB, With DNA \\^tJr 
Aflatoxin Bi requires activation in order to react with DNA or proteins (Croy et ah, 1978). Its 
biochemical mechanism indicates that its bioactivity is associated with the vinyl moiety. Aflatoxin Bi is 
converted by cytochrome P450 enzymes to the reactive electrophilic 8,9-epoxide. The reaction of 8,9-
epoxide with liver DNA and serum albumin forms AFBi-N7-guanine (AFBi-N7-gua) and lysine 
adducts, respectively. It has been found that the binding of AFBi with one of the purine or pyrimidine 
bases in DNA, indicated in figure 2.4, causes mutations which can contribute to carcinogenesis. 
Experimental animals developed liver, kidney, and colon tumours when they were fed AFBi. Some of 
the criteria which have been applied to demonstrate aflatoxin-DNA binding includes alterations in the 
aflatoxin absorption spectrum that occur upon interaction with DNA. 
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There is a shift in absorption maximum (from 363nm to 366-368nm) upon equilibration of 
AFBi with calf thymus DNA in phosphate buffer, (Sporn et. ah, 1966). This shift is accompanied by 
marked hypochromism at 362nm. It was found by Sporn et ah (1966) that 600 moles of native DNA-
phosphorus equivalent bound 1 mole of AFBi. Denatured DNA bound AFBi in a molar ratio of 170 : 
1. Black and Jirgensons (1967) found that aflatoxin binding resulted in gross conformational changes 
in the histone and DNA molecules. 
Figure 2.4 Illustration of aflatoxin Ê  bound to DNA at the guanine base derived from liver (Keeler et at, 
1992). 
Phase II reactions of toxicants are very important in the detoxification of xenobiotics. They 
involve the joining together of a substrate compound with another species that occurs normally in (is 
endogenous to) the body, they are therefore referred to as conjugation reactions (Manahan, 1990). 
Two important enzymes involved in the detoxification of AFBi-epoxide in the hepatocytes are 
the microsomal epoxide hydrolase (EPHX) and glutathione S-transferase Mi (GSTMl). Epoxide 
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hydrolase converts the epoxide into 1.2-dihydrodiols and GSTM1 conjugates the epoxide to 
glutathione, a crucial conjugating agent in the body. Lack or diminution of these enzymes might leave 
more of the epoxide available to bind to DNA, RNA and/or proteins. By binding to DNA, the epoxide 
causes an AGG-to-AGT (arginine to serine) transversion mutation at the third base of codon 249 in 
exon 7 (McGlynn et al, 1995). In proteins, activated AFBi has been shown to interact mostly at the 
lysine part of albumin thereby inhibiting protein synthesis. In DNA it interacts with guanine thereby 
causing mutations. 
2.4.4 Biochemical effects of anatoxins in the liver VA*JA*V 
In animals treated with aflatoxins, the effects of the toxins have been reported to be virtually 
tissue-specific, affecting only the liver, with few exceptions (Wogan, 1966). This generalisation is 
applicable to the toxicity following acute dosing and to the carcinogenicity resulting from chronic 
exposure. Sequential histologic alterations manifest in the hepatotoxicity of AFBi in rat liver have been 
described by Butler and Barnes (1964). 
Carcinogens are either electrophilic molecules or are biologically activated by cytochrome P450 
dependent mixed function oxygenase (MFO). The electrophiles are capable of binding in vivo with the 
informational macromolecules, thus inducing cancer (Ames et al, 1973). Inactivated AFBi 
(procarcinogen) has no reactivity towards nucleophiles. It shows only weak in vitro association with 
DNA. Activated AFBi (ultimate carcinogen) binds to the macromolecules (Coles et al, 1980). 
Using rat studies, many investigators have shown a linear relationship between dietary aflatoxin 
dose and binding to serum albumin and liver DNA (Wild et al, 1986). Dietary AFBi dose also 
correlated well with urinary and liver AFBi-N7-gua levels. Mutational properties of the primary AFBi-
DNA adduct show a predominant G-T transversions, identical to the principal mutation in human liver 
tumours associated with aflatoxin (Bailey et al, 1996). Aflatoxin Bi-hepatic DNA adduct levels in rats 
and rainbow trout correlate well with incidence of liver tumours. These results demonstrate that 
AFBi-albumin and urinary AFBrN
7-gua levels can serve as surrogates for the liver DNA adduct levels. 
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2.5 AFLATOXIN BrEPOXIDE: THE ULTIMATE CARCINOGEN 
The 8,9-epoxide (Fig. 2.5) has been identified as the active form of AFBi (Baertschi et al, 
1988; Rajkumar and Harris, 1993). Other researchers (Swenson et al, 1977; Jacobsen and Humayun, 
1986) have called it the 2,3-oxide, but in this study it will be referred to as the 8,9-epoxide. The 8,9-
epoxide can be synthesised in vitro activation by crude metabolic enzyme preparation (Garner et al, 
1972). There are also two in vitro chemical procedures for the formation of 8,9-epoxide. One 
involves oxidation with the mild organic oxidant chloroperbenzoic acid and the other oxidation with 
dioxirane. The synthesis of AFBi-8,9-dichloride (AFB1-Q2) is also important as it is an electronic 
analogue of AFBr8,9-epoxide. It has been shown that AFB1-Q2 is more carcinogenic than AFBi. 
Aflatoxin Bi-dibromide (AFBi-Br2) is however more susceptible to nucleophilic attack at C-8 than the 
dichloride and thus it was a better model to investigate the action of AFBi-8,9-epoxide before its 
availability by in vitro synthesis. 
Gorst-Allman et al (1977) compared the rates of hydrolysis of AFBi dichloride and dibromide 
in aqueous solution at pH 7.4. The rate of hydrolysis was taken as an indication of the ease of attack at 
the electronegative C-8. This was done by following the bathochromic shift from 360 to 390nm due to 
the formation of the phenolate anion. The Xm of dibromide reaction was found to be 30s at 20°C 
compared with that of the dichloride which was 185s at 20°C. As the 8,9-epoxide has not been 
isolated or detected in biological systems, its role has been inferred from structures of adducts with 
DNA and other bioreceptors. Raney et al (1992) pointed out that the biologically relevant species is 
the exo-8,9-epoxide, which is highly reactive, as opposed to the endo isomer. 
The epoxide, which can be detoxified in vivo by conversion into the *ra«s-diol by epoxide 
hydrase (McGlynn et al, 1995), is extremely labile under non-biological conditions. The epoxide 
intermediate will, therefore, require protection by a hydrophobic environment, if produced on the 
endoplasmic reticulum, during its migration to the site of action with genetic material (RNA or DNA). 
Alternatively, the epoxidation may occur in the nucleus but the presence of suitable cytochrome activity 
has not been demonstrated in this organelle. 
The 8,9-epoxide of AFBi has been prepared using dimethyldioxirane as the oxidant (Baertschi 
et al, 1988; Ferrer et al, 1996) and the properties of dimethyldioxirane have been determined by 
Adam et al, 1986. Aflatoxin Bi 8,9-epoxide is stable for at least 12 hours at room temperature in the 
solid form or in solutions of acetone and methylene dichloride and can be stored for long periods at -
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10°C (Baertschi et al, 1988). The preparation of the epoxide of AFBi contains both the exo- and the 
endo-8,9-epoxides (Fig. 5) in the ratio of 10:1 respectively (Raney et al, 1992). 
The exo isomer was found to be strongly mutagenic in a base-pair reversion assay employing 
Salmonella typhimurium, whilst the endo isomer was found to be essentially non mutagenic (Iyer et 
al, 1994). Apart from S9 fraction epoxidation by A. jlavus in vitro (Saxem et al, 1991) oxidation has 
been shown to occur by lipoxygenase purified from human term placenta and intra-uterine conceptal 
tissues. This supports the speculation that AFBi may be a carcinogen produced by the placenta. 
AFB, endo-&£-epoxi6t, 4 
Figure 2.5 Formation of aflatoxin Bi exo- and endo- epoxides (adapted from Raney et al., 1992) 
Tjalve et al. (1992) showed that microsomal preparations of the bovine olfactory mucosa have 
a much higher ability than liver microsomes to induce covalent binding of AFBi to calf thymus DNA 
and to microsomal proteins. Therefore, inhaled aflatoxins may also have detrimental effects. 
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2.6 AFLATOXIN Bi-ADDUCTS . , 
2.6.1 Introduction 
Researchers have explored new approaches to recognising and predicting toxic exposures of 
humans to aflatoxins and their potential consequences (Wild et al, 1990b). These approaches require 
the development of indicators (biomarkers) which will enable the identification and predictions to be 
made with some certainty (Groopman et al, 1990). The laboratory assay must give a long term 
exposure assessment in a sample obtained non-invasively. Biological markers (biomarkers) can be 
used to recognise reactions, responses, or adverse changes in a biological system at an early stage and 
with certainty and hence biomarker research may be of great value to human health care (Ashby, 
1987). Macromolecular adducts can be detected and quantified using sensitive and sophisticated 
analytical methods (Wild etal, 1990b). 
Previous approaches, using the measurement of unbound aflatoxins, had the disadvantage of 
reflecting relatively short term (a few days) exposure. Such previous approaches were used to measure 
aflatoxin metabolites and/or nucleic acid adducts in human urine, serum, and milk (Groopman et al, 
1988; Wild etal, 1988; Groopman etal, 1993). 
Dose-dependent binding of aflatoxins to DNA (Appleton et al, 1982) and serum albumin 
(Wild et al, 1986) have been shown to occur and this provides the experimentally based rationale to 
investigate such interaction as biomarkers of toxin exposure in people. Wild et al. (1990b) have 
evaluated the methods for quantitation of aflatoxin-albumin adducts. They suggested a combination of 
the hydrolysis enzyme linked immunosorbant assay (ELISA) for large scale screening followed by 
confirmatory analysis in positive samples. 
The two important macromolecular adducts are the DNA adducts (Jennings et al, 1992; 
Tjalve et al, 1992) and the protein adducts (Sabbioni et al, 1987; Wild et al, 1990a). Each of these 
adducts can be studied using different methodologies. Aflatoxin Bi-lysine adduct is formed via the 
same metabolic activation that leads to AFBrDNA adduct formation. Therefore, the level of albumin 
adduct in experimental animals reflects the degree of DNA damage in the liver, which is the target 
organ for experimental AFBi carcinogenesis (Wild et al, 1986; Sabbioni et al, 1987). 
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2.6.2 Proposed mechanism for the formation of the AFBt adduct 
Sabbioni et al. (1987) have proposed that the active species in vivo or in vitro is the 8,9-
dihydro-8,9-diol which is produced rapidly by hydrolysis of the epoxide or dibromide respectively. It 
was found that at physiological pH the dihydrodiol is in equilibrium with the hydroxydialdehyde. Like 
aldoses and glyceraldehydes, alpha-hydroxyaldehydes combine with primary amino groups in proteins 
to form SchifF bases which undergo Amadori rearrangement to alpha-amino ketones. The amino 
ketone is converted by chemical transformations to the pyrrolidine-3-one. This completes the adduct 
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Figure 2.6 Proposed mechanism for tlie formation of AFBi adducts (Sabbioni etai, 1987). 
2.6.3 DNA adducts 
V 
DNA adducts are significant in chemical carcinogenesis. Among the analytical methods 
currently used for the detection and quantitation of DNA adducts are: immunological methods 
(Candlish et al, 1991), fluorimetric methods, and 32P-postlabeling (Gupta et al, 1982). These 
methods extend the detection for DNA adducts to 1 per 106 - 1010 normal nucleotides. Each method 
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has advantages and disadvantages, therefore they play different and sometimes complementary roles in 
biomarker and human biomonitoring. 
2.6.4 Protein adducts , o 
Y 
Protein adducts have been found to be invaluable biomarkers of exposure because they are 
quantitatively better dosage indicators than are DNA adducts and plasma albumin has long been known 
to bind AFBi (Rao et al, 1968). Furthermore, blood proteins are readily accessible (Sabbioni et al, 
1990). Overall reactivity of tissue proteins to common monofunctional alkylating agents like ethylene 
oxide is 1-5 times higher than that of DNA. Proteins of most importance in toxin conjugation are those 
that circulate in blood, i.e., haemoglobin and albumin. Serum albumin and haemoglobin are abundant 
in blood and can be isolated easily. Haemoglobin adducts tend to persist for the lifetime of circulating 
erythrocytes (120 days in humans). Even after several months of last exposure period, haemoglobin 
adducts may still be detected. Albumin adducts are more abundant than those of haemoglobin but can 
only be used for assessing recent exposure, as albumin has a faster turnover than haemoglobin (i.e., a 
half life of 20-25 days), and exists freely in serum. (Albumin is synthesised in the liver endoplasmic 
reticulum, a major site of xenobiotic activation). 
Wild et al. (1990a) have reported that between 12 and 100% of aflatoxin bound to serum 
albumin in children and adults from various African countries, contain aflatoxin albumin adducts. They 
found the level of up to 350pg AFBrlysine equivalent/mg albumin. In Thailand the levels of this 
adduct was lower and no positive sera were detected from France or Poland. The levels of AFGr 
albumin adducts were found to be 5.7 and 2.8 fold lower than that of AFBi. It was therefore 
suggested that AFGi could be used as an internal standard for methods using the measurement of 
aflatoxin-albumin adducts to quantitate human exposure to aflatoxin (Sabbioni and Wild, 1991). 
2.6.5 Analysis of adducts 
Three general methods have been used for the chemical analysis of protein adducts: 
* The adducted protein of interest is isolated and subjected to mild acid- or base-catalysed 
hydrolysis to release the adducting residue from the protein. The free molecule is isolated and 
quantified by conventional analytical methods such as UV absorption spectroscopy. 
18 
* Another method starts with a harsh and complete acid hydrolysis of the protein adduct to 
individual amino acids, which are analysed by conventional means. 
* The third method is specifically for the release of adducted N-terminal valines in haemoglobin 
using a modified Edman degradation method with pentafluorophenyl isothiocyanate (high 
sensitivity, mild degradation conditions). 
The method of choice for isolating albumin from plasma is generally affinity chromatography. 
However, a significant loss of the major human lysine AFBi-adduct occurs in this method because of 
instability of adduct during the cibracon blue affinity chromatography step used in the isolation. A 
more rapid ammonium sulphate precipitation step is, therefore, preferred (Wild etal, 1990b). 
2.7 METHODS OF ANALYSIS FOR DNA AND PROTEIN ADDUCTS 
2.7.1 Immunological methods 
Antibodies recognising specific DNA adducts are available and enable researchers to monitor 
the toxicity, mutagenicity, and carcinogenic properties of these adduct. Immunological methods for 
DNA adduct quantitation are competitive radioimmunoassay (RIA) (Gan et al, 1988), solid-phase 
competitive or non-competitive enzyme-linked immunosorbent assay (ELISA) (Wild et al, 1990b) and 
ultrasensitive enzymatic radioimmunoassay (USERIA). Antibodies have also been used in the 
development of various immunopurification techniques. 
In the RIA technique, the ability of antigen in a sample to compete with a fixed amount of 
radiolabelled antigen for a limiting quantity of antibody is measured. This gives the concentration of 
antigen in the sample. Enzyme-linked immunosorbent assay employs the solid phase-bound antigen 
and a second antibody conjugated to an enzyme. The second antibody conjugated to an enzyme 
increases assay sensitivity (one molecule of enzyme can hydrolyse many substrate molecules). 
Ultrasensitive enzymatic radioimmuno assay is similar to ELISA but the substrate for the second 
antibody is radiolabelled. Sensitivity of USERIA is equivalent or even more than that of ELISA 
(Change/ al, 1994). 
There are two different ways of relating sensitivity to immunoassays. When the amount of a 
given DNA adduct required for precise quantitation is involved, it is said to be absolute sensitivity. 
Relative sensitivity denotes the lowest relative modification level to be detected in DNA. At a given 
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absolute sensitivity, the relative sensitivity of a method depends on the amount of DNA required by the 
system. Immunoassay methods are and have low costs in analysing large numbers of samples. The 
disadvantage of immunological methods, however, is the production of antibodies which require 
extensive development efforts. This also requires prior knowledge of the structure of the DNA adduct 
under investigation. Antibodies are also valuable in immunopurification. Monoclonal antibodies have 
been used in various affinity chromatography procedures to eliminate interfering substances prior to 
analysis by either immunoassays or non-immunological assays (Wild et al, 1990b). 
2.7.2 Fluorimetric methods 
The inherent fluorescent properties of many polycyclic aromatic hydrocarbons (PAHs) and 
compounds with extended heterocyclic structures is of high value in fluorimetric methods (Chang et 
al, 1994). 
Synchronous scanning fluorescence spectrophotometry (SFS) is one such approach. In SFS, 
simplified spectra are generated by scanning both excitation and emission simultaneously with a fixed 
wavelength difference. Synchronous scanning fluorescence spectrophotometry provides a sensitive 
means for the detection of selected DNA adducts but has a limited ability to distinguish between 
closely related compounds. Therefore, SFS has not sufficient resolving power to determine a single 
adduct in a complex mixture. Synchronous scanning fluorescence spectrophotometry is also vulnerable 
to interference by other fluorescence-emitting substances. This implies a need for an additional sample 
cleanup step prior to SFS analysis. Alternatively, FIPLC coupled with fluorescence detection could be 
used (Wild et al, 1990b). 
2.7.3 32P-PostIabeling assay 
32P-Postlabeling assay uses a sequence of steps: 
* enzymatic DNA digestion to the deoxyribonucleoside-3'-monophosphates (dNps), 
* labelling the adducted nucleotides with 32P ATP and T4 polynucleotide kinase (T4PNK) to 
produce the deoxyribonucleoside-3',5-bisphosphates (dpNps), 
* enrichment of adducted nucleotides by the elimination of normal nucleotides and 
* separation and detection by high resolution thin layer chromatography (TLC) and 
autoradiography respectively (Beach and Gupta, 1992). 
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Advantages of P-postlabeling. 
* Sensitivity: the detection limit of one adduct in 106-108 normal nucleotides is readily attained. 
* Assay requirements: minimum DNA requirements for the assay is as low as 1 - 1 Oug 
* Versatility: prior knowledge of adduct composition is not necessary, therefore, multiple 
adducts resulting from exposure to complex mixtures can be detected. 
Disadvantages ofP-postlabeling 
* It is not possible to detect absolute quantitation of an unknown adduct because the efficiency of 
the T4 PNK reaction differs with various DNA adducts. 
* The method will only quantify, reliably, those adducts that can be chromatographically 
separated. 
* The most crucial phase of the 32P-postlabeling assay, which is adduct enrichment, has been 
overlooked. 
* Presently researchers use the technique of butanol extraction (Gupta, 1985) and nuclease P r 
mediated enrichment (Reddy and Randerath, 1986). 
2.8 EXCISED MACROMOLECULAR ADDUCTS 
Under normal physiological conditions, nucleic acids and proteins are broken down by various 
catabolic processes. The adducted portion of the degraded macromolecule is then excreted through 
urination. The relatively large volumes of urine that can easily be obtained from exposed individuals 
aid in the analysis of the extremely low concentrations of the breakdown products. Although excised 
macromolecular adducts only reflect the most recent exposures to xenobiotics, molecular epidemiology 
information has been derived using these biomarkers in human populations. Like in DNA and protein 
adducts, conventional analytical techniques and immunoassays can be used for the quantitation of 
excised DNA adducts (Chang et al, 1994). 
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2.9 MYCOTOXIN DOSAGES, ADDUCTS AND CARCINOGENESIS. 
2.9.1 Internal Dose 
Internal dose refers to the actual amount of xenobiotic absorbed into the organism. It is 
determined by measuring the xenobiotic or its metabolite in the body fluids, tissues, or excretory 
products. Blood and urine are most commonly analysed because of the accessibility and quantity, e.g., 
AFBi in urine serves as an indication of exposure to dietary aflatoxins. The advantage of internal dose 
is that it avoids the uncertainties of determining the concentration of the toxicant in the environment, 
the root of exposure, and the toxicant absorption rate. The disadvantages of internal dose are that it 
overestimates the biological effect of chemicals, that require activation e.g., AFBi. This means that the 
metabolic rate of the chemical is not taken into account. Internal dose also underestimates the 
biological effect of chemicals that act directly, i.e., these chemicals act on the tissue of first contact. 
2.9.2 Biologically Effective Dose 
Biological effective dose is the amount of chemical needed to induce a biological response or 
consequence. The interaction of electrophiles with nucleophiles is the primary step in carcinogenesis. 
Adducts are invaluable as biomarkers, because they represent the amount of material interacting with 
the critical subcellular, cellular, and tissue targets. Adducts are therefore, considered to be the 
biologically effective dose of xenobiotics. 
Direct acting alkylating chemicals or metabolically activated intermediates bind covalently, at 
.*, nucleophilic sites on DNA to form adducts. The determinant in binding is the nucleophilicity of the 
reaction site and the electrophilic strength of the reactive chemical. There are adducts which are not 
directly mutagenic, e.g., 7-methyldeoxy-guanosine, whereas others like those formed at 06-guanine, 
O2- and O4 thymidine, or 02-cytosine, are considered promutagenic. The position of the adduct is, 
therefore, important in DNA-adduct quantitation. 
N7-methylguanines are more abundant and persist longer because they are repaired more 
slowly than the 06-methylguanines. N7-methylguanines may serve as surrogate markers for the 06-
methylguanines. Unrepaired promutagenic adducts can cause cell death, initiation of neoplastic 
development by inducing DNA damage and gene mutation that lead to oncogene activation, 
perturbation of the regulation of cell proliferation, triggering uncontrolled cellular growth. Similar 
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effects may also be produced through repair errors. Deoxyribonucleic acid adducts are, therefore, a 
relevant indicator of the biologically effective dose of a carcinogen (Chang et ai, 1994). 
Protein adducts in haemoglobin and albumin and urinary (DNA base) adducts have been used 
as surrogates for exposure estimates. Both haemoglobin and albumin adducts are accessible, plentiful, 
persistent and stable (not subject to repair). Their quantity is also dose related and correlates well with 
DNA adducts. Some substances that form adducts in the body are the N-nitrosamines, PAHs, 
aromatic amines and AFBi. This study concentrates on AFBi-adducts. 
2.10 AFLATOXIN AND HUMAN HEALTH 
There is a growing concern over the impact of aflatoxins and other mycotoxins on human 
health because, besides AFBi having been a proven human carcinogen, aflatoxins are postulated to: 
* play a role in the aetiology of kwashiorkor, 
* increase neonatal susceptibility to infection and malignant diseases, 
* compromise immune response to prophylactic immunisation and 
* may play a role in the pathogenesis of diseases in heroin addicts (Smith et al, 1994; Smith et 
al, 1995). 
The role of aflatoxins in human disease includes: epidemiological correlations between 
aflatoxins in food and hepatoma in Africa, i.e., Kenya, Swaziland, Mozambique and South Africa 
(Peers et al, 1987); in Thailand (Munoz and Bosch, 1987; Autrup et al, 1987); and in the Peoples 
Republic of China (Yea et al, 1989); severe liver disease in children in India after ingestion of 
aflatoxin-contaminated foods, and epidemiological and clinical correlations between Reye's syndrome 
in children and dietary exposure to aflatoxin in Thailand. The young and malnourished are susceptible 
to the effects of aflatoxins. There is, therefore, a need for the investigations of long-term exposure to 
aflatoxins in children especially in areas where protein energy malnutrition is endemic. 
Saad etal. (1995) investigated exposure of infants to AFMi from mother's breast milk in Abu 
Dhabi. Their results demonstrate that exposure to aflatoxins is not a problem solely in rural 
communities of developing countries, with low incomes, but may also be a problem for relatively 
wealthy countries, if they lack the legislative measures and the educational infrastructure to highlight 
and control the level of aflatoxin in food and feeds. The importance of legislative measures is 
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confirmed by the observation that countries with stringent quality control, e.g., Singapore, have low 
degree of individual exposure to aflatoxins (Chao et al., 1994). 
Multiple factors are involved in the interaction of aflatoxin with albumin. Compounds with 4-
hydroxycoumarin ring bind to serum albumins and the introduction of a hydrophobic group to a 
coumarin compound greatly increases its anticoagulant action and its binding to albumin. Aflatoxin Bi 
is much more effective than 4-hydroxycoumarin in prolonging the blood clotting time of rats. The 
comparative effective doses were 56 x lO^mM AFBi to 93 x 10"3mM 4-hydroxycoumarin (Bassir and 
Bababunmi, 1972). 
Kwashiorkor is a serious disorder of children which is widespread in the tropics. Kwashiorkor 
was previously thought to be caused by protein deficiency but over the past fourteen years a steady 
accumulation of evidence incriminating aflatoxins in the aetiology of kwashiorkor has been observed. 
Speculations are that kwashiorkor might result from chronic aflatoxin poisoning (Anon, 1984), but 
whether it is prime factor for the development of kwashiorkor is still unknown (Abdulmagid, 1993). It 
is not clear whether the fundamental difference in the metabolism of aflatoxins in kwashiorkor and non-
kwashiorkor patients is causally related to kwashiorkor or is a consequence of the disease but it is 
speculated that aflatoxins causes kwashiorkor by damaging the liver, which becomes unable to 
manufacture albumin. Low level of albumin then lead to the disease (Read, 1990). 
Protein energy malnutrition (PEM) is a dominant type of malnutrition world-wide and 
embraces all disorders attributable to lack of protein and calories. These disorders include marasmus 
and kwashiorkor. Protein energy malnutrition serves as a euphemism for starvation. There is evidence 
that PEM is very widespread and is a major associated cause of death in early childhood. 
There are no mysteries in the pathogenesis of marasmus because it is the childhood equivalent 
of starvation and the features are characterised by varying degrees of wasting (Hendrickse, 1982). On 
the other hand the pathogenesis of kwashiorkor remains obscure. It was earlier thought that it is caused 
by severe protein deficiency with relative carbohydrate excess, but this is no longer tenable. It is now 
known that there are no essential differences in the protein/energy ratios in the diets of children who 
develop marasmus or kwashiorkor. Clinical features of kwashiorkor range from slight oedema, in a 
depressed, unhappy child, to a gross oedema, extreme misery and apathy, grotesque skin lesions and 
hair changes in children whose biochemistry is in a state of chaos and whose immunity is depressed 
(Hendrickse et al, 1982). 
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There is no record of kwashiorkor in Europe when other forms of malnutrition in children were 
rife. Whether kwashiorkor is purely a nutritional disease or whether malnutrition renders children 
susceptible to etiologic factors which precipitate the syndrome remains unexplained. 
Hendrickse et al. (1982) investigated blood and urine samples for their aflatoxin content by 
HPLC. They used kwashiorkor, marasmic kwashiorkor, marasmus and normally nourished children. 
Aflatoxins were detected more often, and at higher concentrations, in sera from children with 
kwashiorkor than in the other malnourished and control groups. In the kwashiorkor children, they also 
detected aflatoxicol (a metabolite of AFBi and AFB2) which was not detected in the controls. That 
showed a difference in metabolism between children with kwashiorkor and the other groups. They 
concluded that either the children with kwashiorkor have a greater exposure to aflatoxins or that their 
ability to transport and excrete aflatoxins is impaired by the metabolic rearrangements associated with 
kwashiorkor. 
Hendrickse et al. (1982) screened a total of 177 sera. They detected aflatoxin in the serum of 
children in all nutritional groups included in their study. Aflatoxins were detected least in the controls 
(15.9%), marginally more often in children with marasmus (19.3%) and marasmic kwashiorkor 
(21.9%) and most often in those with kwashiorkor (36.4%). A similar trend has also been observed by 
Ramjee et al, 1992. Aflatoxins were more often detected in boys than in girls (in the three 
malnourished groups). They had evidence of a positive association between poor nutritional state and 
the presence of aflatoxins. The serum concentrations of the individual AFB!, AFB2, AFGi, AFG2, 
AFMi, AFM2, and aflatoxicol were highest in children with kwashiorkor and lowest in controls. 
A total of 250 urine specimens were screened for aflatoxins and aflatoxicol was not detected. 
Children with aflatoxins had lower concentrations of aflatoxin in their urine than the other groups. The 
highest concentrations occurred among children with marasmus and marasmic kwashiorkor. This was 
firm evidence that children in the Sudan are exposed to aflatoxins in their diets. 
In kwashiorkor children there may be a greater exposure to aflatoxin or there may be an 
impairment of the ability to transport and excrete these substances consequent on the metabolic 
derangements associated with kwashiorkor. It is therefore, important to measure aflatoxin levels in 
food cooked in the homes (food on the plate) of all groups of patients. However, it is clear that 
children with kwashiorkor are at greater risk from aflatoxin than normal children. It might occur that 
25 
after initial insult to the liver, impaired ability to handle and excrete aflatoxins creates a vicious cycle, in 
which serum aflatoxin values rise, as the ability to handle these substances progressively declines. 
Aflatoxins were detected in the livers of a small number of children who died of kwashiorkor in 
South Africa and Nigeria. This invites speculation about the significance of these findings in relation to 
the unanswered questions about the aetiology and pathogenesis of kwashiorkor (Hendrickse, 1982). 
There has been a recent report of the occurrence of kwashiorkor in a fully breast-fed infant and in an 
identical twin (Oyelami et al, 1995). This does not agree with the belief that the aetiology of 
kwashiorkor is wholly nutritional. Moreover, aflatoxins were detected in the organs of these children 
on post-mortem examination. 
Most doctors are poorly informed about the environmental hazards constituted by aflatoxins 
and other mycotoxins because these toxins have been ignored by the medical profession (Hendrickse, 
1982). Some of the toxic metabolic effects of aflatoxins in animals include: fatty degeneration of the 
liver, depressed albumin synthesis, depressed enzyme synthesis, immunosuppression, haemorrhagic 
phenomena, and depressed glucose metabolism. Light microscopic histology of the liver in acute 
toxicity have demonstrated bile duct proliferation and fatty infiltration, while ultrastructural studies 
have revealed marked changes in the endoplasmic reticulum, mitochondria and nucleoli (Coulter, 
1987). 
Investigations in Sudan have shown that many commonly eaten foods are contaminated by 
aflatoxins which can be detected in the blood and urine of local children. Such findings support a 
hypothesis that aflatoxins (and possibly other mycotoxins) may be factors in the pathogenesis of 
kwashiorkor. It is not easy to reconcile this concept with the classical, purely nutritional explanations 
for the syndrome, but it accords with the geographical distribution, seasonal incidence, dietary 
associations and patho-physiology of kwashiorkor (Hendrickse etal, 1982). 
Apeagyei et al. (1986) analysed the autopsy liver specimens from 22 children in Ghana who 
had died of kwashiorkor. They used both TLC and HPLC and of the subjects, 20 had AFBi at a 
concentration range of 62 to 4409pg/g of tissue. Two of the liver specimens showed the presence of 
aflatoxicol, Ylpglg and 99pg/g respectively. This confirms that AFBi and aflatoxicol is present in livers 
of children with kwashiorkor. Apeagyei et al (1986) did not detect any of the oxidative metabolites of 
AFBi (AFMi, AFPi, and AFQj). This implies an impaired microsomal mixed function oxidase system 
in kwashiorkor patients. Aflatoxins cannot, therefore, be detoxified by oxidation and removed from 
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the liver as would normally occur. It must however be emphasised that the nature of association 
between kwashiorkor and aflatoxins remains unexplained, although an association has been established. 
2.11 MONITORING EXPOSURE TO AFBi USING AFBrLYSINE, AFBr 
ALBUMIN AND AFBrPROTEIN ADDUCTS 
Exposure to aflatoxins has been monitored using different methods. In correlation studies the 
method was by extrapolation from analysis of food sample contamination whilst in the case-control 
studies the method was by questionnaire. In all these studies exposure assessment was relatively 
imprecise (Wild et al, 1990b). While such data is important, it only measures the internal dose, i.e., 
the amount of a particular chemical agent ingested by an individual. Among the factors influencing the 
internal dose are the intake, distribution, metabolic (in)activation and excretion, all of which are not 
accounted for in the internal dose. This lead to the development of new approaches to the 
determination of exposure assessment of aflatoxin. Aflatoxin Bi has been shown to bind to albumin in 
a quantitative manner (Skipper et al, 1985, Wild et al, 1986, Dirr and Shabort 1986, Sabbioni et al, 
1987). The major adduct formed in the binding of AFBi to albumin is the AFBi-lysine adduct. 
Different methods have since been used to quantitate the level of aflatoxin bound to albumin. 
Such methods include the measurement of: 
* aflatoxin Bi-albumin intact adduct 
* aflatoxin Bi-lysine adduct 
* aflatoxin Gi-lysine adduct 
* protease digest of AFBi-albumin. 
Gan et al (1989) used the intact albumin adducts in their fluorimetry experiments (excitation 
and emission set at 320 and 420nm respectively). The intact albumin was chosen because of the 
instability of AFBi-lysine adduct during isolation steps {Ua — 8hrs). In their experiment they found that 
non-adducted native serum albumin also has a fluorescent profile when excited by 320nm light (i.e., a 
background fluorescence from native albumin is present). Their laser induced fluorescence (LIF) was 
unable to conduct the time-resolved LIF study on the elimination of background fluorescence from 
sample fluorescence with signal subtraction method. Their alternative was, therefore, to record and 
digitally store the fluorescence of native albumin, measure the fluorescence of adducted albumin and 
subtract the background by standard routines. 
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Sheabar et al. (1993) used the digested proteins method. They found that increasing protease 
to protein ratio up to 0.1 (w/w) resulted in enhanced detection of AFBi adducts. Higher ratios did not 
show further increases. Incubation of serum proteins with protease (4.1 : 1 w/w) for more than 15 hrs 
at 37% showed no significant improvement in detection of protein adducts. Approximately 30% of the 
highly polar aflatoxin-protein adducts are lost during immunoaffinity chromatography of serum protein 
digest. Only 20-35% recovery of AFBi-albumin adduct are reported due to losses during 
chromatographic isolation of albumin as well as the AFBi-lysine adduct (Sheaber et al, 1993). Losses 
as high as 95% of the AFBi-lysine adduct have been reported (Wild et al, 1990b) due to a large 
number of experimental steps (Sheaber et al, 1993). 
Sabbioni et al (1990) suggested that human serum could be prepared for aflatoxin-lysine 
analysis by direct pronase digestion without prior specific albumin isolation. The mechanism of 
decomposition of AFBi-lysine remains obscure (Sabbioni et al, 1987, Sabbioni et al, 1990). Wild et 
al (1990b) indicated that AFBrlysine is probably not the only aflatoxin containing molecule present 
after hydrolysis, other aflatoxin-peptides may occur. Thus, it may be of value to screen for conjugates 
of aflatoxins and amino acids other than lysine. 
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CHAPTER 3 
PRODUCTION OF AFLATOXINS AND PREPARATION OF 
AFLATOXIN Bi -EPOXIDE 
3.1 PRODUCTION OF AFLATOXINS 
3.1.1 Introduction 
Since the discovery of aflatoxins in the 1960s, a number of studies have been conducted to 
determine conditions for their maximum production. This included the production of aflatoxins by 
different strains of Aspergillus flaws and A. parasiticus on semi-synthetic (Davis et al, 1966) and 
natural media. It was soon apparent that strains of these species had the ability to produce relatively 
large amounts of the aflatoxins. For example, Diener and Davis (1966) screened isolates of A. 
flavus for aflatoxin production on groundnuts, peanuts and on a nutrient liquid medium. Ninety 
percent of the isolates produced AFBi. Reddy et al. (1971) have shown that as high as 30mg of 
aflatoxin per 100ml of a defined medium, containing sucrose, asparagine, and salts in both 
stationary and shaken cultures can be produced. High yields have also been achieved using yeast 
extract-sucrose medium (YES) (Park and Bullerman, 1981). 
Isolation and purification of aflatoxins is an important aspect in view of the fact that other 
toxins can be co-produced with aflatoxins, especially cyclopiazonic acid (Gallagher et al, 1978; 
Trucksess et al, 1987; Blaney et al, 1989; Gqaleni et al., 1996). Purification of aflatoxins can be 
achieved by preparative TLC separation on silica gel G60 plates (Grimeno, 1979; Stahl, 1988). The 
techniques used to produce pure aflatoxins for subsequent use in this project are outlined in this 
chapter. 
3.1.2 Materials and Methods 
All reagents were of analytical grade unless stated otherwise. Thin layer silica gel G 
chromatography plates (20 x 20cm on aluminium backing) and silica gel G 60 were purchased from 
Merck. 
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The fungal culture 
Aspergillus parasiticus (NIX) was maintained on potato dextrose agar (PDA, appendix lb). 
A spore suspension was prepared from one Petri dish of culture by adding 10ml of (0.1%) sterile 
sodium dodecyl sulphate and agitating with a sterile glass rod. This was vortexed and filtered 
through sterile glass wool to produce a spore inoculum. 
Culture flasks were prepared by dispensing 100ml yeast extract sucrose medium (YES, 
appendix lb) into 250ml Erlenmeyer flasks, plugging with cotton wool and autoclaving at 15psi for 
15 minutes. Each flask was inoculated with 1ml of inoculum and incubated in a shake incubator at 
28°C at 180 revolutions per minute for 48 hours. The culture fluid from 10 flasks was then filtered 
to remove mycelium and pooled. The filtered fluid was then extracted with an equal amount of 
chloroform twice. The chloroform extracts were dried by passing through sodium sulphate and then 
rotary evaporated to dryness, leaving a yellow powder which was redissolved in 15ml of chloroform 
and purified by preparative TLC as described below. 
Preparation of preparative thin layer chromatography plates 
Glass silica TLC plates, 20 x 20cm, were washed thoroughly with detergent, hot water, 
distilled water and finally dried with acetone. The plates were placed in a spreader and a slurry of 
pouring consistence was prepared by mixing 30.0g silica with distilled water (70ml). The slurry 
was poured into the spreader (set to a gap of 0.3 mm) and the plates were spread evenly by smoothly 
pushing the spreader over the plates. The layer was allowed to set and the coated plates were placed 
in a rack and air dried. They were then activated overnight in an oven, at 110°C. 
Streaking of plates and extraction ofAFBi from silica 
Important: Aflatoxin Bi is a human carcinogen, therefore, great care was exercised to 
avoid exposure to AFBi and its derivatives. Caution was exercised when AFBi was extracted 
from silica to avoid inhalation ! 
The plates were evenly streaked with the crude aflatoxin solution on an origin 1cm from one 
edge of the plate using a Pasteur pipette. The streak was repeated thrice to concentrate the sample. 
The plates were developed by ascending chromatography in chloroform/acetone (90:10), after 
which they were dried in a fume cupboard. The aflatoxins were then visualised under long wave 
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UV light for the presence of fluorescent bands. The Rf value of each toxin was determined 
according to the equation: Rf = distance migrated by spot/distance migrated by solvent front. Under 
UV light, each fluorescent band was scored using a sharp needle and the silica gel containing the 
band was scraped, using a spatula, into a sintered glass funnel and washed with portions of acetone 
(25 ml in total) and the silica discarded. The acetone was evaporated on a rotary evaporator under 
vacuum, with the temperature set at 60°C. The residue was dissolved in a minimum amount of 
chloroform and rechromatographed until the toxin was chromatographically pure. 
Quantitation ofaflatoxin Bi 
The purified toxin was dissolved in 500ul acetone and a lOu.1 aliquot was transferred to 
another vial and evaporated to dryness. The residue was dissolved in 2ml spectrophotometric grade 
ethanol and the solution scanned (200 - 700nm) using a Milton Roy Spectrophotometer. The 
concentration of AFBi was calculated from the absorbance at a specified wavelength using its molar 
extinction coefficient (Cole and Cox, 1981). 
3.1.3 Results 
The purified toxins were recognised with respect to their Rf values, which were as follows: 
AFBi = 0.46 ; AFB2 = 0.36 ; AFGi = 0.31 ; AFG2= 0.24 and their absorption spectra (see Fig. 3.1 
for that of AFBi). Aflatoxin Bi was the toxin of major importance because it was required for the 
synthesis of AFBi-8,9 epoxide. 
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Figure 3.1 Spectrophotometric scan of AFB] in ethanol (spectrosol) monitored at 200 
700nm. 
Plate 3.1. Ailatoxin extracts streaked on silica TLC plate and viewed under UV at 366nm. The chromatogram 
was developed in chloroform: acetone (90 : 10). 1=AFB,, 2 = AFB2, 3 = AFGi, 4 = AFG2 and 5 
represents the origin. 
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Plate 3.2 Aflatoxin B] spotted on silica TLC plate in duplicate and developed in chloroform : acetone (9 : 1). 
The plate was viewed under UV at 366nm. 
The amount of AFBi recovered was calculated as follows:-






(A is absorbance and e is the molar extinction coefficient) 
Therefore, 42 ug in the 2ml ethanol solution, which means: 
42 ug in lOul of the original sample. Therefore, in 0.5ml there were: 





In order to obtain aflatoxins of adequate purity from cultures of A. parasiticus, preparative TLC was 
used, as the four major aflatoxins are very similar in chemical structure. The best solvent system to 
separate the toxins on preparative silica gel plates was found to be chloroform/acetone (90:10) 
which gave sufficient separation of the toxins as four fluorescent bands (Plate 3.1) and removes 
fungal lipids to the solvent front. The Rf values obtained were consistent with those reported in the 
literature for chloroform based solvent systems (Dutton, 1993) and gave a pattern on TLC similar to 
that reported by Yabe et al. (1988) for extracts from culture material of A parasiticus. 
Two problems were encountered during the isolation procedure. One was the presence of 
orange pigments, which often co-chromatographed with the aflatoxins. These are probably 
anthraquinone metabolites related to anatoxin biosynthetic intermediates, which have been reported 
before (Donkersloot et al, 1972; Stahl, 1988; Chuturgoon, 1990). They were also isolated for other 
studies and were effectively separated from the aflatoxins by addition of small amounts (10ul) of 
acetic acid to the TLC solvent system. 
Another problem associated with preparative TLC of aflatoxins is the high ratio of silica gel 
to aflatoxin required to affect a separation. This results in grams of silica gel being scrapped from 
the plates with micrograms of toxin present. Losses are inevitable due to decomposition of the toxin 
on the silica and strong binding of an aflatoxin residue that could not be dislodged even with 
excessive washing with polar solvents. Losses of toxin impregnated silica gel were minimised by 
the use of glazed paper to pool silica scrapings and washing glassware well with the appropriate 
solvents. 
The amount of pure AFBi obtained was 2.1mg/l of original YES culture fluid and, although 
this is low as compared to other workers (30mg/100ml of culture fluid, Yabe et al, 1988), it was 
adequate for some of the investigations to be done. The UV spectra of the isolated toxins were 
similar to that reported in the literature (Cole and Cox, 1981) and indicated that the isolated toxins 
were of the required purity. 
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3.2 PREPARATION OF AFLATOXIN Bi-EPOXIDE 
3.2.1 Introduction 
Epoxidation is an important means of activating AFBi making it more susceptible to 
nucleophilic attack. It occurs by adding an oxygen atom between two unsaturated carbon atoms to 
form a mixture of two isomers, the exo- and endo forms. Exo-epoxidation of AFBi has an effect of 
increasing the toxicity of the parent compound by this activation, because it can react with 
important cellular macromolecules (McLean and Dutton, 1995; Manahan, 1990). In living systems 
AFBi is converted into the exo-epoxide by the so called phase I reactions mediated by the 
cytochrome P450 in the endoplasmic reticulum. In cellular detoxification by the phase II reaction, 
the epoxide readily undergoes conjugation with other species naturally present in the body e.g., 
glutathione, to form a substance (conjugation product) that can be readily excreted (Stark, 1980). 
The epoxide may be synthesised in vitro, chemically, using either w-chloroperbenzoic acid 
or dioxirane reagent. Although epoxidation by w-chloroperbenzoic acid is usually simple, the 
dimethyldioxirane procedure remains the method of choice for preparation of exo-epoxide in 
crystalline form. This is because fewer impurities need to be removed during the crystallisation 
process and epoxidation with dimethyldioxirane is efficient and rapid (Iyer and Harris 1993). The 
objective reported here was to prepare the epoxide using dimethyldioxirane, so that its binding 
properties, especially with amino acids, could be evaluated. 
3.2.2 Materials and Methods 
All reagents were of analytical grade unless stated otherwise. Aflatoxin Bi was either 
purchased from CSIR, Pretoria S. A. or produced in the laboratory. Cellulose TLC plates 20 x 
20cm were obtained from Merck. Potassium monoperoxysulphate was purchased from Sigma 




Dimethyldioxirane was prepared from potassium monoperoxysulphate as a distilled solution 
in acetone (Murray and Jeyaraman, 1985) as follows:-
A mixture of distilled water (10ml), acetone (6ml), sodium bicarbonate (12mg) was 
prepared in a 500ml three-necked round bottom flask with constant stirring (magnetic stirring bar). 
The round bottom flask was equipped with a solid addition flask containing potassium 
peroxymonosulphate (24mg). An air condenser was connected to a dry ice condenser which was 
attached to a receiving flask (100ml), cooled in ice water. The solid potassium peroxysulphate was 
added in small portions (for 1 minute) with stirring to commence the reaction. After three minutes, 
a slight vacuum was applied to the reaction assembly. The yellow-coloured dimethyldioxirane-
acetone solution collected primarily in the receiving flask. The solution, 8ml, was stirred briefly 
with 50mg anhydrous MgS04, filtered, and stored in a freezer for subsequent use. 
Preparation of qflatoxin Bi epoxide 
Aflatoxin Bi (lOmg), was dissolved in 2ml dry acetone and 1ml dioxirane reagent was 
added. After twenty minutes (at room temperature), 5ul of the solution was spotted on a silica TLC 
plate against AFBi standard and developed as stated below (to check if epoxidation had taken 
place). The solvent and excess reagent were removed from the rest of the reaction mixture by 
evaporation under a stream of nitrogen and 1.5ml dry dimethylenedichloride was added. A fraction 
of the solution (4|il) was mixed with 4ul 1M HC1 (for trans-6\o\ experimentation). The remaining 
solution of the epoxide was stored at -20 °C for subsequent use. 
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Confirmation of the presence of the aflatoxin Bj -8,9 epoxide 
The silica TLC plate, spotted with the reaction mixture (epoxide), was developed in 
chloroform : ethylacetate : isopropanol (CEI) 18:1:1. The TLC plate was dried under a stream of 
warm air and tested for the presence of the epoxide as follows:-
The chromatograms were immersed in epoxide staining solution I (Appendix I), for 1 to 2 
seconds and heated to 130°C for 25 min. They were then cooled to room temperature and immersed 
for 1 to 2 seconds in epoxide staining solution II (Appendix 1). 
3.2.3 Results 
The Rf value of the epoxide, which gave a green chromophore with the epoxide stain, was 
found to be 0.16 in CEI, whilst that of AFBi was 0.54 under the same conditions (Fig. 3.2). The 
spectrophotometric scan (Fig. 3.2) showed that almost all AFBi was converted to the epoxide. 
Aflatoxin Bi-epoxide showed a maximum wavelength at 266 and 367nm (Plate 3.3). The scan of 
AFBiO (Fig. 3.2) was different from that of AFBi (Fig. 3.1, page 32). 
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Plate 3.3 Anatoxin Bi - epoxide reaction mixture (1) spotted against AFBi (2) on silica TLC plate and 
developed in chloroform : ethyl-acetate : isopropanol (18 : 1 : 1). The plate was viewed under long 
wave UV at 366nm. 
LnSTftOJU.MID (290.9 - 750.9) mKIDE 
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Figure 3.2 Spectrophotometric scan of AFBiO (200 - 750nm) in ethanol. 
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3.2.4 Discussion 
Initial attempts to prepare the dimethyldioxirane reagent were not successful. The liquid 
that distilled over was colourless, an indication that dimethyldioxirane was too diluted (should be 
yellow) and did not have the distinctive odour of dioxirane. It was found from further 
experimentation that the vacuum generated to allow for distillation at reduced temperatures was 
critical, the optimum being around 50mm of mercury. Although the reagent is reported to be stable 
for up to five months when stored at -20°C, in this case it was used on the same day of production to 
synthesise AFBiO. 
Examination of the reaction mixture from treated AFBi by TLC showed a single spot at Rf 
0.16 in the CEI solvent system as compared to the parent AFBi at Rf 0.54. This change in Rfvalue 
is to be expected as the epoxide is more polar than AFBi and has a higher molecular mass 328 as 
compared with 312 for the parent AFBi toxin. That it was an epoxide was confirmed by its reaction 
with the epoxide detecting reagent to give a green colour. Aflatoxin Bi does not react with this 
reagent. 
Unfortunately it was not possible to use TLC to further purify the epoxide as it had to be 
eluted with highly polar solvents, e.g., methanol, from the silica gel which resulted in the formation 
of a methoxy decomposition product. No attempts were made to separate the endo from the exo 
form of the epoxide, as this was unnecessary in the further series of reactions to be done. 
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CHAPTER 4 
REACTION OF SELECTED N„-ACETYL AMINO ACIDS WITH 
AFLATOXIN Br8,9 EPOXIDE 
4.1 Introduction 
Amino acids (AA) are the basic structural units of proteins. They contain an amino group, 
a carboxyl group, a hydrogen atom and a distinctive R group bonded to a carbon atom, which is 
called the alpha (a) carbon. Twenty kinds of side chains varying in size, shape, charge, hydrogen 
bonding capacity, and chemical reactivity, are commonly found in proteins including serum 
albumin and therefore, are available for reaction with AFBi-8,9 epoxide (AFBiO). 
The bound AA likely to react are: lysine (LYS), which has already been identified in an 
adduct form, arginine (ARG), and asparagine (ASN); tyrosine (TYR); serine (SER); histidine 
(HIS); and tryptophan (TRP). In order to prepare amino acid-AFBi-adducts, Na acetyl AA were 
reacted with AFBiO. Na acetyl AAwere used because they have the alpha amino group blocked, 
ensuring that this group could not react, and that any derivatisation would occur on the side 
chain. Methods to detect and monitor the product formed between an Na acetyl AA and A F B ^ 
include TLC and UV spectrophotometry. 
4.2 Materials and Methods 
The Na acetyl derivatives of: LYS, SER, HIS, TRP, TYR, ARG and ASN were obtained 
from Sigma Chemical Co. (St. Louis, USA). Aflatoxin Bi epoxide was prepared as described in 
Chapter 3. 
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4.2.1 Preparation of the Adduct 
An Na-acetyl AA (10 mg) was dissolved in 4ml of 0.05M sodium phosphate buffer pH 
7.4, and 0.4mg of AFBiO, dissolved in lOOul acetone, was slowly added with mixing. The 
development of a yellow coloured complex was noted on the addition of the epoxide. The 
reaction was allowed to continue at 35°C, with shaking, for 86 hours. 
4.2.2 Qualitative Analysis 
Spectrophotometric scan 
After 86 hours the UV scan of the Na-acetyl amino acid-epoxide mixtures were taken 
(200nm - 700nm) and compared. These complexes were also spotted on cellulose thin layer 
chromatography (CTLC) plates and developed in butanol/water/acetic acid (BWA) (12:5:3). The 
plates were dried and viewed under long wave (366nm) UV light and the presence/absence of 
AFBiO noted. The plates were then treated with chlorine and sprayed with tolidine reagent 
(appendix I) to confirm the presence/absence of AFBi-8,9-epoxide- Na-acetyl AA complexes. 
4.3 Results and discussion 
Thin layer chromatography coupled with UV spectroscopy offers an important 
complementary tool for monitoring the formation of aflatoxin adducts with biochemical 
molecules. The former technique is mainly used for qualitative evaluation and to a lesser extent 
semi-quantitation. In these studies reaction mixtures of Na-acetyl AA and AFBiO were spotted 
onto cellulose plates as these are far less polar than silica gel layers and allow chromatographic 
movement of amino acids, and their derivatives in suitable solvent systems such as IWA and 
BWA. In this case BWA was chosen as the ammonium hydroxide in the IWA system reacts with 
the AFBiO adduct to form yellow decomposition products. 
Although AFBiO adducts should fluoresce due to the coumarin chromophore in the 
system the fluorescence is diffuse and is over laid by streaking due to unreacted and decomposed 
AFBiO. In order to visualise the adducts the chromatograms were sprayed with tolidine after 
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treatment with chlorine gas. Although Na-acetyl AA in theory could react in this system, only the 
adducts did to any degree and this was a convenient way to decide when reaction had taken place. 
On TLC of the various reaction mixtures it was found that only amino acids with reactive nitrogen 
atoms in their side chains had formed adducts (Fig. 4.1). These were the Na-acetyl derivative of 
arginine, lysine and histidine. From observation of the intensity of the spot on the TLC plate the 
degree of reaction was in that order. It seems that the more basic AA react more favourably with 
the epoxide than histidine, which is more likely, as they are more nucleophilic in nature but the 
actual yields were found to be in the descending order of arginine, histidine and lysine. It also 
seems that both the exo and endo forms of the epoxide react under these conditions as opposed to 
the exo- form only, in vivo. Although it is not apparent from the TLC plate the spots did exhibit 
diffused fluorescence under UV light which confirmed their identity as adducts, because no 
corresponding fluorescenses were observed in the chromatograms of the other AA reaction 
mixtures. 
The use of spectroscopy in these studies was also useful and allowed for the quantitation 
of the adducts from their absorption at selected wavelengths and the application of literature 
extinction coefficients. Amino acids normally absorb at 210nm (Fig. 4.2, 4.4 and 4.6) with 
aromatic AA absorbing at 280nm (Apendix II). Aflatoxin Bi absorbs at 365nm with its derivative, 
AFBiO absorbing at 266 and 367nm (Fig. 3.2). The adduct of AA with AFBiO absorb at 395nm 
and it follows that other adducts should absorb in the range 390 - 400nm at neutral pH. Normally 
this form is only generated in alkaline pH but in this case it is due to the presence of the open ring 
form of the bisfuran system due to the formation of the adduct (Fig. 2.6). All three acetyl AA 
shown to react with AFBiO gave this characteristic peak (Fig. 4.3, 4.5, and 4.7). Arginine adduct 
absorbed at 392nm and using the lysyl-AFBi extinction value gave a concentration of 0.21mg/ml 
in the original phosphate buffer; histidine absorbed at 391nm and gave a concentration of 
0.31mg/ml and lysine at 397 and gave a concentration of 0.18mg/ml. The lysyl adduct (Fig. 4.5) 
also showed a small peak at 349nm which is possibly due to unreacted epoxide or its 
decomposition product. The reaction mixtures containing Na-acetyl serine, tyrosine, and 
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Figure 4.1 Thin layer chromatograms of Na acetyl AA-AFBiO mixtures (developed in BWA) after 
treatment with chlorine and spraying with tolidine reagent. Compounds with N acyl linkages 
show up as coloured spots. Na acetyl AA used were : 
Lane 1 Na-acetyl arginine, 
Lane 2 Na-acetyl serine, 
Lane 3 Na-acetyl asparagine, 
Lane 4 Na-histidine, 
Lane 5 Na-acetyl tyrosine, 
Lane 6 Na-acetyl tryptophan and 
Lane 7 Na-acetyl lysine. 
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Plate 4.1 Photograph of CTLC plate (Fig 4.1) viewed under UV (366nm) before chlorination -
treatment and tolidine spray reagent. The bright spots at 2,3, 5 and 6 are free AFBiO 
indicating negative reaction with the acetyl amino acids. 
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Figure 4.2 Spectrophotometric scan of Na-acetyl-arginine monitored at 200 - 750nm in 0. IM 
sodium phosphate buffer pH 7.4. 
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Figure 4.3 Spectrophotometric scan of Na-acetyl-arginine-AFBjO mixture monitored at 200 • 
750nm in 0. IM sodium phosphate buffer pH 7.4. 
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Figure 4.4 Spectropliotometric scan of Na-acetyl-lysine monitored at 200 - 750nm in 0. IM 
sodium phosphate buffer, pH 7.4. 
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Figure 4.5 Spectrophotometric scan of Na-acetyl-lysine-AFB^ mixture monitored at 200 
750nm in 0. IM sodium phosphate buffer, pH 7.4 
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Figure 4.6 Spectrophotometric scan of Naacetyl-histidine monitored at 200 - 750nm in 0. IM 
sodium phosphate buffer, pH 7.4 
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Figure 4.7 Spectrophotometric scan of Na-acetyl-histidine-AFBiO monitored at 200 - 750nm 
in 0.1M sodium phosphate buffer pH 7.4. 
4.4 Conclusion 
From this work it has been shown that AFBiO combines with more than one amino acid in 
vitro. This was supported by both TLC and spectroscopic data. It therefore, follows that the 
epoxide would react with more than one amino acid residue in vivo. This is similar to the 
situation with DNA, which was thought for some time to react with AFBiO through its guanine 
residues but cytosine (Yu et al, 1991) and more recently (Iyer et al, 1994) adenine have also 
been found to react. Other workers (e.g., Wild et al, 1990b) have also suggested that adducts 
other than lysine are formed in vivo, as peptides formed from albumin enzyme digests not 
containing lysine have been shown to have adducted AFBi. It seems highly probably that these 
will be adducts of histidine and arginine as shown by preliminary studies (Myeni et al, 1997). 
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CHAPTER 5 
PREPARATION OF AFLATOXIN Bj-ADDUCTS OF DNA, LYSINE AND ALBUMIN 
5.1 Introduction 
A number of assays may be used to recognise and quantitate the product of the interaction 
of AFBiO with either DNA or protein. These methods have been reviewed in section 2.7. In this 
study, assays that quantitate defined adducts of DNA or protein, have been opted for, because they 
are specific as far as adduct detection. These methods require the initial preparation of pure and 
chemically defined adducts, which are then searched for in the somatic tissue of exposed 
individuals. Such methods require substantial chemical and biochemical preparations and involve 
the selection of DNA or protein adducts most worthy of study. Aflatoxin Bi-guanyl, AFBi-DNA, 
AFBi-lysyl and AFBi-albumin adducts were selected because it has been shown that AFBi interacts 
mostly with the lysine residues of albumin and with the guanine moiety of DNA. 
Aflatoxin Bi adducts may be detected using high performance liquid chromatography 
(HPLC), high performance capillary electrophoresis (CE) and UV spectrophotometry. High 
performance capillary electrophoresis is a separation technique based on electrophoresis in narrow-
base capillaries, usually 25 - 75|im inner diameter (id). Capillaries are usually filled with only 
buffer and the advantages of capillaries are mostly related to the Joule, since they have a high 
electrical resistance. This enables the application of very high electrical fields (100 to 500V/cm), 
with minimal heat generation. The heat that is generated is efficiently dissipated by the large 
surface area-to volume ratio of the capillary. High electrical fields result in short analysis times and 
high efficiency and resolution. An important aspect of CE practice is electro-osmotic, or 
electroendosmotic flow (EOF). This is the bulk flow of liquid in the capillary and is caused by the 
surface charge on the interior capillary wall. 
Electroendosmotic flow causes movement of almost all species, regardless of charge, in the 
same direction. Normally, the flow is from the anode to the cathode. Anions will be flushed 
towards the cathode since the magnitude of the flow can be more than an order of magnitude greater 
than their electrophoretic mobilities. Cations, neutrals, and anions can, therefore, be 
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electrophoresed in a single run because they all migrate in the same direction. Cations migrate 
fastest, neutrals are all carried at the velocity of the EOF but are not separated from each other, 
anions migrate slowest because of their attraction to the anode but are still carried by the EOF 
toward the cathode (Heiger, 1992). 
High performance capillary electrophoresis is a rapidly growing separation technique, with a 
diverse application range. It has been used on a number of analyses of different compounds like 
haemoglobin variants (Castagnola et al, 1995); human serum proteins and apolipoproteins 
(Lehmann etal, 1995); seed albumins (Salmanowicz, 1995); and underivatized amino acids (Guo 
etal, 1995). It offers simpler method development, minimal sample volume (1 to lOnl) and lack of 
organic waste. 
High performance liquid chromatography was selected because when coupled with 
fluorescence detection it is more sensitive than CE. The columns for HPLC are generally made of 
stainless steel and are manufactured so that they can withstand pressures of up to 5.5 x 107 Pa (8000 
p.s.i.). Straight columns of 20 to 50cm in length and 1 to 4mm in diameter are generally used 
though smaller capillary columns are available. The choice of mobile phase to be used in any 
separations will depend on the type of separation to be achieved. Isocratic separations may be made 
with a single solvent, or two or more solvents mixed in fixed proportions. Alternatively a gradient 
elution system may be used where the composition of the developing solvent is continuously 
changed by use of a suitable gradient programmer. Generally this involves use of two pumps. One 
of the most important features of an HPLC system is the pumping system. 
It is imperative that the sensitivity of the detector system is sufficiently high and stable, 
since the quantity of material applied to the column is frequently very small. Commonly the 
detector is a variable wavelength ultraviolet-visible spectrophotometer, fluorimeter, a refractive 
index monitor or an electrochemical detector. Recently there has been an interfacing of HPLC to a 
mass spectrometer. 
In this study CE was used to analyse the products of the reactions of macromolecules with 
AFBiOand HPLC the monomer and hydrolysis products of the macromolecular adducts. 
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5.2 Materials and Methods 
5.2.1 Materials 
Na-acetyl-l-lysine, proteinase K, and diazald were all purchased from Sigma Chemical Co. 
(St. Louis, U.S.A.), albumin, DNA, acylase I and amberlite (IR 120, Na) standard grade particle size 
1.18mm were supplied by BDH Laboratory Supplies (England). Tolidine and ninhydrin spray 
reagents were prepared as indicated in appendix la. 
Spray Reagents 
Ninhydrin and tolidine spray reagents were used for detection of free amines and nitrogen 
containing compounds which can be converted into chloramines respectively. 
5.2.2 Preparation of Adducts and Derivatives 
Aflatoxin Bi Albumin 
Aflatoxin Bi 8,9-epoxide (0.8mg, prepared as described in Chapter 3) was added to 40mg 
albumin (fraction V) in 0.05M sodium phosphate buffer (4ml), pH 7.4 and incubated at 37°C for 24 
hours. The UV spectrum of the product of reaction was determined at a 4-hour interval, by mixing 
lOul of the AFBi albumin sample with 3 ml phosphate buffer. The AFBi albumin solution was also 
examined by CE to follow the course of the reaction. 
After 24 hrs at 37°C, 5ul of the sample was spotted on cellulose TLC plate, and developed 
two dimensionally in (1) BWA both ways and (2) IWA/BWA to check for fluorescence. The plate 
was observed under UV and sprayed with ninhydrin. The remaining sample was digested with 
proteinase K as follows: proteinase K (6.7mg, dissolved in 2ml sodium phosphate buffer, 0.05M, 
pH 7.4) was added to 2ml of reaction mixture and incubated at 37°C overnight, with shaking. The 
digest was then spotted on cellulose TLC plates and developed in BWA. The plates were observed 
under UV, sprayed with ninhydrin and different amino acids identified using standard Rf values 
(Jones and Heathcote, 1966). The sample was then filtered and examined by HPLC. 
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Aflatoxin Bj LysylAdduct 
Na-acetyl-L-lysine (23.5 mg), was dissolved in 2ml sodium phosphate buffer, 0.05 M, pH 
7.4 and incubated at 37°C with 0.8mg AFBi-epoxide. After 24 hours the reaction mixture was 
freeze dried and extracted with acetone (10ml) to remove acetone soluble residues. The acetone 
was pooled, and run on a silica TLC plate, developed in CEI/TEF. The non-acetone soluble residue 
was dissolved in a minimum amount (300ul) of buffer and 5ul was spotted on a CTLC plate and 
developed in two separate solvent systems: the first solvent system was IWA for the first direction 
and BWA for the second direction; and the second solvent system consisted of BWA for both 
directions. Tolidine and ninhydrin spray reagents (appendix I) were used for detection of Na-acetyl 
lysine derivatives. The sample was then incubated with acylase I (2.5mg, dissolved in 4ml 0.1M 
phosphate buffer, pH 7.4) for 24 hours at 37°C. 
Clean Up ofAdduct By Ion Exchange 
Amberlite resin, IR 120, Na standard grade particle size 1.18mm, was packed halfway a 27 
x 50mm glass column which had been previously filled with distilled water. Care was taken to 
make sure that no air spaces were in the column. The amberlite column, was then prepared by 
washing with distilled water (2000ml) until it was neutral. The column was washed with 1M HC1 
(20ml), to convert the resin to its acid form and then it was washed with distilled water (20ml) until 
the effluent was neutral. The Na-acetyl-lysine-AFBi mixture was freeze-dried in a Virtis freeze 
dryer. The powder was dissolved in 4ml of distilled water and run on the column, elution of Na-
acetyl-lysine-AFBi was effected with 25ml distilled water. Excessive Na-acetyl-lysine was washed 
off with ammonia (2M, 15ml). The column was regenerated by washing with 1M NaOH (20ml) 
followed with distilled water (1000ml) until the effluent was neutral and reconstituted into its acid 
form as above. 
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Methylation ofNa-acetyl-Amino Acids 
This reaction was carried out to block the carboxyl group of the N-terminal AA to ensure 
that only the side chain functional group reacted. Two methods were used: 
(i) Diazomethane Method 
Ethanol (95%, 25ml) was added to a solution of potassium hydroxide (5g) in 8ml water in a 100ml 
distillation flask fitted with dropping funnel and an efficient condenser for distillation. A solution of 
21.5g diazald in 200ml of the ether was added through a dropping funnel over a period of about 25 
minutes to the ethanolic potassium hydroxide solution warmed to 65°C in a water bath. The yellow 
distillate was passed onto a receiver flask cooled to 0°C in an ice bath. After the addition, a further 
40ml of ether was added and slowly distilled until the distillate was colourless. The etherical 
solution contained about 3g of diazomethane. Because of the toxic and explosive nature of 
diazomethane, the apparatus was kept in a fume cupboard and the reaction mixture was topped up 
with dry ether at all times. The following Na-acylated amino acids were reacted with the 
diazomethane: 
Nonpolar/hydrophobic amino acid i.e., tryptophan; polar but uncharged amino acids i.e., 
serine, cysteine, tyrosine, asparagine and lysine; positively charged R group amino acids i.e., 
arginine and histidine; negatively charged amino acid i.e., aspartic acid. 
(ii) Esterification Method 
Na-acetyl-l-lysine, 20mg, was weighed, suspended in 400ul of high purity methanol and 
reacted with thionyl chloride (three drops). After an hour at room temperature, the reaction mixture 
was neutralised with solid sodium bicarbonate (6mg). Dry analar acetone (2ml) was used to extract 
the ester. A sample of the acetone extract (5uT) was spotted on a CTLC plate and developed in two 
dimensional chromatography to check for methylation of Na-acetyl-l-lysine: 2 x BWA; and 
IWA/BWA. The acetone was evaporated and the ester was again spotted as mentioned above. 
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Reaction of Methylated Amino Acids With Aflatoxin Bj Epoxide 
Methylated Na-acetyl-l-lysine was dissolved in phosphate buffer at pH 7.2 and reacted with 
AFBi-epoxide and spotted on TLC. Different solvent systems in two dimensions were used, i.e., 
IWA/BWA, 2x BWA and 2x CEI to characterise the product by CTLC. The reaction was repeated 
at pH 5.6 and 8.6. 
Reaction o/DNA With Aflatoxin Bj Epoxide 
A solution of AFBi-epoxides (0.2mg), in anhydrous acetone, lOOul was added with stirring 
to 2mg calf thymus DNA dissolved in 1.0 ml sodium phosphate buffer, pH 7.2 at 10°C. After thirty 
minutes at room temperature the reaction mixture was acidified to pH 2.0 with 0.1 M HC1. The 
reaction mixture was heated at 80°C for thirty minutes and filtered through 0.45 u.m filter and 
subjected to UV spectrophotometry. Guanyl AFBiO adduct was prepared in exactly the same way, 
substituting guanine for DNA. 
Preparation of Albumin and Serum Protein Adducts 
Serum (80fj.L> pH 7 was added to 0.1 mg epoxide (dissolved in 40ul acetone) and incubated 
overnight at 37°C. Albumin (20mg) was dissolved in 0.05M sodium phosphate buffer, pH 7.4. The 
reaction product and albumin solutions were each (5ul) examined by Poly-Acrylamide Gel 
Electrophoresis (PAGE) and a Serum Protein Electrophoresis (SPE) kit. 
5.2.3 Determination of Thin Layer Chromatographic Characteristics of Products 
The following compounds in addition to Na-acetyl lysine were reacted with AFBiO: lysine, 
methyl N-acetyl lysine albumin and albumin digest. Each of these compounds (O.llg) was 
dissolved in 4ml phosphate buffer (pH 7.4; 0. IM) and 20ul was spotted on CTLC plates. Cellulose 
plates were run two-dimensionally using either HS/BWA, or TWA/BWA solvent system (Haworth 
and Heathcote, 1969). The compounds were also spotted on silica plates and developed uni-
dimensionally on CEI. The plates were sprayed with 0.2% ethanolic ninhydrin. 
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5.2.4 Instrumental Analysis of Reaction Products 
High Performance Liquid Chromatography ofAflatoxin Bi lysylAdduct 
Two HPLC chromatographic instruments were used to analyse the lysyl AFBi adduct 
depending upon the exact conditions used and availability of instrumentation, namely a Spectra 
Physics fitted with a Cis reverse phase (RP) Merck column and fluorescence detector. The other 
instrument used was a Hewlett Packard 1090 HPLC system fitted with a Cg RP Phenomenox 
column. 
Two systems were used: 
(i) The chromatography consisting of a 2 minute linear gradient solvent system similar to that 
used by Sabbioni etal. (1990) with a QgRP column (Merck). 
(ii) An isocratic solvent system consisting of 0.01M sodium phosphate buffer pH 7.2/methanol 
(50 : 50 or 70 : 30). In later analyses a Cg Phenomenox column (Merck) was used with sodium 
phosphate buffer at 0.1M pH 3.1. 
In all cases the flow rate was set to 0.5ml per minute and injections were repeated at least 
three times to check reproducibilty. 
High Performance Capillary Electrophoresis ofMacromolecularAdducts 
Analysis was performed on Hewlett Packard CE using a UV detector. Aflatoxin Bi 8,9-
epoxide formed as described in Chapter 3, was reacted with an albumin solution (20mg albumin, 
dissolved in 0.05M sodium phosphate buffer pH 10). The reaction was allowed to continue for 12 
hours at 37°C. The mixture was then filtered and analysed using CE under the following 
conditions:- 0.1M sodium phosphate buffer pH 3, injection at 200.0 mbars, voltage set at 15 Kv. 
The CE wavelengths were set at 210, 260, 280, 293, and 400nm. The adduct was detected. An 
albumin solution was used as a standard and was also analysed using CE conditions similar to those 
for the adduct. 
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5.3 Results and Discussion 
Having digested AFBi-albumin mixture, a number of AA residues (Table5.1) were 
identified using standard Rf values. Some of the AA residues showed slight fluorescence under UV 
light, which indicated their positions (Rf values), which was an indication of AFBiO binding. It was 
not possible to identify all the AA as the Rf values did not correspond to known values. This could 
be explained partly due to the possible interaction between AFBiO and AA. A better separation of 
the residues was effected using two dimensional TLC in BWA both ways. This solvent system was 
used to avoid possible decomposition of adducts by NH3 in the IWA system. 
For purification purposes, Na-acetyl-lysine-AFBiO mixture was passed through a cation 
exchange column. This was done so that Na-acetyl-lysine could be separated from Na-acetyl-
lysine-AFBiO. The principal feature underlying ion exchange chromatography is the attraction 
between oppositely charged particles. Amino acids, like many biological, molecules have ionisable 
groups and the fact that they may carry a net positive or negative charge was utilised in separating 
mixtures of such compounds. Na-acetyl-lysine-AFBiO would be less basic than Na-acetyl-lysine 
and as cation exchangers possess acid groups there would be no attraction and the adduct would 
pass through the column. Na-acetyl-lysine, however has both a basic and acidic group and would 
bind to the column. 
Hydrolysis ofaflatoxin Bi-albumin 
After the hydrolysis of the protein as mentioned above, the following amino acids were 
identified using standard Rf values:-
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Exchange of ions at the exchange site is thought to occur instantaneously and is an 
equilibrium process: 
RS03" . . . Na
+ + ^aH 3 R' RSO3. ..NH3R' + Na
+ 
exchanger counter charged bound exchanged 
ion molecule molecular ion 
to be ion 
exchanged 
Although other workers (Sabbioni et al, 1990) have recommended the use of Na-acetyl 
lysine to avoid the reaction of the a amino group with AFBiO, initial work on this reaction 
indicated that a certain amount of decomposition of the adduct took place particularly under the 
conditions of TLC. A possibility was that the a carboxyl group also took part in the reaction and in 
order to exclude this it was decided to methylate the Na-acetyl AA. Initially methylation was done 
using diazomethane but yields were low and the alternative method using esterification with 
methanol and thionyl chloride proved more effective. The reaction of methylated amino acids with 
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AFBiO was found to be favoured at pH 8.6 and 7.2, but not at pH 5.6. this suggests that lysyl-AFBi 
production is not well promoted at pH 5.6. This information is essential when preparing AA-AFBi 
adducts. When Guanine was incubated with AFBi, at pH 7.2, a shift in absorption maximum was 
observed. The shift was from 362nm to 365nm (appendix lc). Similar shifts have been observed 
by Sporn et al, 1966. A similar trend was observed with DNA. 
Initially difficulties were encountered on the HPLC of the AFBiO adduct because of the 
build up of pressure in the pumping system. This was traced to the use of the gradient solvent 
system which caused the polar components of the reaction mixture to precipitate out on the top of 
the column when the solvent mixture became methanol rich. In order to overcome this an isocratic 
system was used (phosphate buffer/methanol 50 : 50) but this also caused a steady build-up of 
pressure, again possible because of slow precipitation. On increasing the buffer content to 70% the 
intensity of the adduct peak decreased and the retention was substantially increased. 
These problems were finally overcome when a C% Phenomenox column was employed 
together with 0.1M phosphate buffer (pH 3.1). Under these conditions the adduct had a retention 
time of 3.5 minutes (Fig. 5.1) on the Spectra Physics system and 3.2 minutes (Fig. 5.2) using the 
Hewlett Packard 1090 instrument. The respective values of AFBx were 6.4 minutes on the Spectra 
Physics (Fig. 5.4) and 7.4 minutes (Fig. 5.3) minutes using the Hewlett Packard 1090 instrument. 
The peaks were found to be reproducible within a range of ±0.2 minutes for repeated injections. 
Under acid conditions (pH 3.1) the UV absorption spectrum of AFBi-lysine adduct shifted from 
390nm to 370nm (Fig.5.5). Similar pH dependency of the UV spectra has been observed by Garner 
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Figure 5.1 HPLC profile of AFBrlysine conjugate. The conditions were:- 0.02M sodium 
phosphate buffer, pH7.2 
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Figure 5.2 HPLC profile of AFBi -lysine conjugate. The elution conditions were:- 50% methanol: 50% 0.1M 
sodium dihydrogen phospliate pH 3.1. The flow rate was set at 0.5ml/min, using a Q reverse phase 
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Figure 5.3 HPLC (1090 Hewlett Packard) profile of A F ^ (2.2ugfail). 
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Figure 5.6 UV absorption spectrum of AFB, -lysine adduct monitored at 200 - 600nm. 
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Capillary Electrophoresis 
Both standard albumin and albumin conjugated with AFBiO were separated on CE with 
retention times of 10.32 minutes and were detected at their UV absorbance at 210nm (Fig. 5.8). On 
monitoring these molecules at 400nm no response was observed for the free albumin but a 
substantial signal was found for the adduct (Fig. 5.7). Presumably this absorbance is due to the 
coumarin chromophore in the AFBi residues. This is an important finding as it should be possible 
to directly examine blood serum for the presence of albumin conjugates that absorb at 400nm. 
Whilst other adducts may contribute to such a signal it could perhaps act as an elimination screen 
for patients being monitored for exposure to AFBi in their diet. Such patients include children with 
kwashiorkor who routinely have higher AFBi adduct levels in their blood. Clearly a rapid bulk 
screening method for such patients would be advantageous. 
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Figure 5.7 Capillary electrophoresis of anatoxin Bi -albumin adduct monitored at 400run. 
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Figure 5.8 Capillary electrophoresis of aflatoxin Bi-albumin adduct at 210nm. Unbound albumin also exhibit 
absorption at this wavelength. 
It can be seen from Plate 5.1 that AFBiO binds covalently to albumin and that there was no 
evidence from the electrophoretogram to suggest that other proteins do so in vitro. This may be due 
to the lack of suitable amino acid residues in their primary structure in comparison to albumin, 
which would, therefore, react preferentially. The in vivo situation is likely to be different for various 
reasons, (see Chapter 6) e.g., AFBiO seems to bind to DNA in preference to proteins (Garner et al. 
1979). There is also difference in the binding of AFBi and AFGi epoxides to DNA, the former 
binding more strongly than the latter in kidney (Garner et al. 1979). 
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Plate 5.1 Serum protein electrophoresis of 1: serum; 2 : serum-AFBi-epoxide; 3 : albumin; and 4: albumin-




DETECTION AND MEASUREMENT OF AFLATOXIN Bi-LYSINE ADDUCT IN 
HUMANS 
6.1 Introduction 
In the previous chapters it was shown that AFBi conjugates could be detected using HPLC 
by fluorescence as well as UV detection and by CE. Moreover, their absorbance characteristics 
could be determined using UV absorption spectrophotometry. The number of cases in which AFBi 
has been detected in liver biopsies of HCC patients and blood and urine samples in children with 
kwashiorkor in King Edward Hospital VIII (KEH), Durban, is high (Bux, et al, 1994; Ramjee, 
1990). As a follow-up to such studies it has been of importance to make a brief survey and 
investigate whether such patients would have AFBi-lysine conjugates which would indicate the 
extent to which AFBi had been present in the patients' bodies. 
The study presented in this chapter was, therefore, aimed at searching for the presence of 
AFBi-lysine adducts from human blood samples. The detection was carried out so as to compare 
the presence of such conjugates in patients suffering from kwashiorkor and liver cancer to control 
patients (those patients suffering from neither of these conditions). Ethical approval for this study 
was obtained from the Ethics Committee, University of Natal, Medical Faculty and consent was 
sought from concerned patients or their parents. 
6.2 Materials and methods 
6.2.1 Materials 
All reagents were of analytical grade unless stated otherwise. Whole blood (3 - 5ml) was 
collected from KEH at the Paediatrics Out patient Department (POPD) and in the wards, using 
heparin free tubes. Proteinase K (EC 3.4.21.64) and Serva Blue G were obtained from Sigma 
Chemical Co. (St. Louis, U.S.A.). 
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6.2.2 Sample preparation 
Blood was kept at 37°C to facilitate the process of clotting. Serum was obtained by 
centrifugation and immediately aliquoted into 1.5ml Eppendorf tubes, in volumes of 0.5ml. The 
samples were properly labelled and stored frozen at -20°C until they were required. Twenty nine 
blood samples, divided into nine kwashiorkor, ten liver cancer and ten control patients were 
analysed by HPLC for the presence of AFBi-lysine conjugates. Control samples were collected 
from patients who had been admitted to KEH for conditions other than liver cancer or kwashiorkor. 
Twenty nine blood samples were analysed for the presence of free AFBi. The samples were 
divided into fifteen kwashiorkor, six HCC and eight control patients obtained as indicated above. 
Total protein determination in the serum 
Protein content of serum was determined by the Bradford method (Bradford, 1976) as 
described below. 
Preparation of Bradford reagent 
Serva Blue G (50mg) was dissolved in 24 ml of absolute ethanol and transferred into a 
500ml volumetric flask. Phosphoric acid, 85% (w/v), 50ml, was slowly added with shaking and the 
final volume was brought to 500ml with distilled water. The Bradford reagent was stored in the 
dark at room temperature until it was required. 
Albumin standard (1.5mg/ml) 
Albumin (15mg) was weighed and completely dissolved in 10ml of distilled water. 
* A sample of serum, 1 5JLL1, was diluted to 1.0ml with distilled water. 
* From the diluted, sample a small portion (lOOul) was transfered into a 10ml test tube. 
* A series of standards were prepared as follows: 
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Standard albumin, ul (1.5mg/ml) 
Distilled water, u.1 
Corresponding to the following in mg 



















* The Bradford reagent (5ml) was added to each tube and vortexed gently. 
* Absorbance was read at 595nm after 2 minutes. The albumin content of the samples were 
calculated from the standard curve and corresponds to the concentration (mg albumin/ml serum) 
given in the above table. 
0.29 0.62 1.02 1.2 
Protein concentration (mg/ml) 
1.45 
Figure 6.1. A protein standard curve using albumin and Bradford assay. 
Albumin extraction 
* Sera (0.5ml) were placed in a water bath at 55°C for 45 minutes to inactivate any human 
immunodeficiency virus. 
* Samples were cooled on ice for 5 minutes and 1.5 volumes of cold saturated ammonium 
sulphate were added drop-wise. 
* The mixture was vortexed and centrifuged at 9000 x g for 15 minutes, at 0°C to precipitate 
immunoglobulins. 
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* The supernatant containing albumin was removed and 100u.l of 1M acetic acid per 500ul 
serum volume was added to adjust the solution to pH 5 and precipitate the albumin. 
* Albumin was collected by centrifugation as above and immediately, following removal of 
supernatant for TLC determination of the free aflatoxins, the albumin was redissolved in a volume 
of phosphate buffered saline (PBS, O.IM, pH 7.4) equivalent to twice that of the starting volume of 
sera. 
Albumin hydrolysis 
Determination ofaflatoxin Bi-lysine from albumin 
The solutions of albumin in phosphate buffered saline, (2mg/ml, as determined from the 
standard curve) were digested with proteinase K, digesting 3mg albumin with lmg enzyme. The 
digests were centrifuged at 2 700 RPM at 0°C and the supernatants were filtered through 0.22um 
membrane filters before they were analysed by HPLC using UV detection as described in chapter 5 
on page 56. The concentration of lysine-AFBi (ng/ml) in the standard was calculated using 
(extinction coefficient) s at pH 4 (appendix Ic) values of Sabbioni et al. (1987). 
Free Aflatoxins 
For free aflatoxin determination, blood samples (0.5 ml) were mixed with an equal volume 
of chloroform, and the mixture vortexed for three minutes. The chloroform layer was removed and 
fresh chloroform was added and the procedure was repeated three times. The chloroform extracts 
were pooled together and evaporated to dryness. The residue was reconstituted in 100JJ.I of 
chloroform. The chloroform extracts were then spotted on silica TLC plates and developed in 
chloroform : acetone (9:1) to check for the presence of unbound aflatoxins. The number of samples 
that were analysed for free aflatoxins were as follows : 6 obtained from liver cancer, 15 
kwashiorkor, and 8 control patients. 
6.3 Results and Discussion 
Figure 6.2 illustrates that one of the six samples from the HCC patients had unbound AFBi 
whereas one of the fifteen kwashiorkor and none of the control patients showed the presence of 
AFBi by TLC. The concentration of free AFBi in the HCC patient was higher than that in the 
kwashiorkor patient, by visual comparison of the TLC plate. However, it must be borne in mind 
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that TLC is mainly a qualitative technique, with low sensitivity as compared to HPLC. It is 
interesting that no control patients revealed the presence of free aflatoxins, and one out of the six 
HCC patients was positive for AFBi. 
The results for free AFBi in blood samples, however, do not tell us much concerning long 
term exposure of the individuals to aflatoxins. The reason is that once aflatoxins are ingested, they 
undergo biological changes which may result in excretion of the toxin. So, exposure to aflatoxins 
does not necessarily mean that an individual will have free toxins in their systems for any length of 
time. However, the presence of free AFBi implies the exposure of the individual to this toxin. A 
major possibility during biological changes of AFBi in the body, is the formation of AFBiO. This 
epoxide rapidly conjugates with macromolecules to form AFBi-macromolecular adducts. Because 
these macromolecular adducts have much longer life in the body, they are a better dosage indicator 
of individual exposure to aflatoxins than a measurement of free aflatoxins. Consequently, free 
aflatoxin determination may be used for a short term exposure while AFBi-macromolecular 
conjugate determinations may be used for long term exposure assessment. 
The processes controlling the formation of aflatoxin adducts in the human body are several, 
inter-related ones and therefore, give rise to a complex situation. Initially the process was over 
simplified in that, it was thought that a certain amount of aflatoxin in the diet gave rise to a certain 
level in the blood, which then damaged various cellular functions and was then excreted. However, 
early studies on rats revealed that AFBi was a powerful carcinogen and probably gave rise to 
hepatocellular carcinoma in humans when ingested over long periods at a chronic level (Munoz and 
Bosch, 1987). Consequently simple absorption, circulation and excretion of the toxin was unlikely. 
It became apparent (Wild et al, 1986) that AFBi could covalently link with blood proteins and 
tissues and this, coupled with the observation that the cytochrome P450 system of the liver converted 
AFBi to its true active form, the epoxide (Ramsdel et al, 1991) gave a basis for understanding its 
action in the body. 
This now leads to a much more complicated situation when considering the relation of 
absorption, circulation and excretion of the toxin in the body. In particular it presents difficulties in 
understanding and interpreting the presence and concentration of albumin-toxin adducts in the 
blood. In its most simplest forms it might be argued that the adduct merely acts as a bio-marker and 
the higher the level the greater the immediate exposure of the patient to AFBi in their diets. The 
formation of AFBiO-albumin adducts is controlled by two main processes: the uptake of AFBi by 
the blood from the digestive processes, which in turn depends on the level in the diet and; the 
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activity of the cytochrome P450 which is a heterogeneous system with certain molecular types 
having the ability to generate the epoxide and others not. In addition it is subject to induction so a 
patient being exposed to a sudden large dose of toxin may not in fact produce much of the epoxide. 
The subject of AFBi excretion is also complicated. Free toxin may be excreted in the urine 
(Gan et ah, 1988; Groopman et ah, 1993), as well as adducts, including conjugation with guanine 
(main detoxification system (Degen and Newman 1978; 1981)) nucleic acid bases (Groopman et 
ah, 1985) and amino acids (Sabbioni et ah, 1987). The enzymes microsomal epoxide hydrolase 
(EPHX) and glutathione S-transferase Mi (GSTM1) are also very important, as their diminition 
leaves more of the epoxide available for binding to DNA, RNA and/or proteins (McGlynn et ah, 
1995). The activity of the detoxification process could therefore, greatly influence the levels of both 
free and conjugated toxin. The appearance of base and amino acid conjugates presumably reflects 
the presence of macromolecular adducts and their subsequent catabolism. 
The findings in this limited study indicate that patients with HCC have the highest mean 
level of albumin adduct in their blood (3.48ng lysyl-AFBi / mg albumin) followed by kwashiorkor 
patients (1.18ng lysyl-AFBi / mg albumin). In its most simplistic form this would indicate that the 
highest degree of exposure was in HCC patients. From the consideration outlined above it could 
mean other things, e.g., higher cytochrome P450 activities, perhaps as a result of genetic 
predilections, less efficient glutathione conjugating abilities or slower turnover of albumin in the 
body or all of these. It seems that in kwashiorkor patients, they are less capable of metabolising 
AFBi which leads to higher levels of free toxin in their blood (Hendrickse et ah, 1982). Why they 
should then have higher levels of adduct than the control samples is not clear. 
A more worrying aspect of this study is the presence of adduct in all the controls, although 
at a lower mean level (0.83ng lysyl-AFBi / mg albumin). Previous work (Ramjee, 1990) on maize, 
the food staple of most Black people entering KEH shows only sporadic contamination with AFBi, 
which is certainly not at a level and frequency to explain the general presence of AFBi conjugates in 
their blood. Clearly more work is needed in order to identify the source of AFBi in the diet, which 
is more likely to be in oil seeds such as groundnuts. 
King Edward VIII Hospital admits patients from as far as the rural areas of Northern 
KwaZulu-Natal where the population still depends on home grown maize as their main source of 
diet. It is in this context then that the presence of lysine-AFB! even among the control patients 
should be looked at. Some of these patients may have, at one stage in their life history, been 
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exposed to aflatoxins, which is evidenced by the presence of AFBi-lysine conjugates even among 
the control patients. Wild et al. (1990a) has also indicated that between 12 and 100% of sera 
collected from children in various African countries contained aflatoxin-albumin adducts. The 
adverse effects of aflatoxins in the body are numerous but liver suffers the most. Therefore, it is 
possible that impairment of detoxification mechanism in both kwashiorkor and HCC patients, 
explains accumulation of the adducts in the blood of such patients. 
Methods for AFBi macromolecular conjugate determinations are, however, still new. They 
still need some further developments. All the twenty nine samples that were analysed showed the 
presence of AFBi-lysyl conjugate. Using the extinction coefficients of lysine-AFBi, the standard 
was found to contain 61.47 ng/ml lysyl-AFBi (Table 6.1). Figure 6.3 shows that the mean lysyl-
AFBi levels were highest in HCC patients (Table 6.4), followed by kwashiorkor patients (Table 6.3) 
and were least in control patients (Table 6.2). There was a mean 1.4 fold increase in levels of 
lysine-AFBi from control to kwashiorkor patients and the increase was 4.2 from control to HCC 
patients (Fig. 6.4). The method of mycotoxin-macromolecular adduct determination has potential, 
particularly because it has been shown that the mycotoxin, AFBi binds with more than one AA in 
vitro. Aflatoxin Bi-macromolecular adduct determination can, therefore, be used to search for the 
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Figure 6.2 A chart comparing the presence of unbound aflatoxin Bi in kwashiorkor, hver 
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Figure 6.3 High performance hquid chromatography profile of AFB] -lysine conjugate from a 
blood sample of a hver cancer patient. 0. IM sodium phosphate buffer, pH 3.1. 
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Table 6.1 Amount of lysyl-aflatoxin Bi adduct derived from HPLC 




AFBi (ng/ml in 
buffer)* 
'61.47 
Amount of lysyl-AFBi 
(ng lysyl-AFB, / mg Na-
acetyl lysine)1 
24.59 
Percentage yield (%)2 
40.25 
* Concentration of lysyl-AFBi = Arm x molar mass x 1000 u.g/ml 
£248 
= 0.002 x 501 x 1000 ug/ml 
16 300 
= 0.06147ug/ml 
= 61.47 ng/ml 
ng/ml standard x 4.0ml /10mg Na-acetyl lysine) 
Total amount of lysyl-AFBi in 4ml of buffer = 61.47ng/ml x 4ml 
= 245.9ng 
2 ng adduct/ng AFB i O x 100% = 245.9ng adduct x 100% 
MW adduct 
MWAFBiO 






Table 6.2 Lysyl-aflatoxin Bi adduct in the blood albumin control patients as 


























Amount of lysyl-AFBi 


























peak area of sample x concentration of standard in ng/ml 
peak area of standard 
= peak area of sample x 61.47ng/ml 
129.70 
concentration of sample in ng/ml in 1ml sample is equivallent to 3mg of digested albumin 
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Table 6.3 Lysyl-aflatoxin Bi adduct in the blood albumin kwashiorkor 

























Amount of lysyl-AFBi 











Amount of lysyl-AFBi (ng 











peak area of sample x concentration of standard in ng/ml 
peak area of standard 
= peak area of sample x 61.47ng/ml 
129.70 
concentration of sample in ng/ml in 1ml sample is equivallent to 3mg of digested albumin 
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Table 6.4 Lysyl-aflatoxin Bi adduct in the blood albumin HCC patients as 


























Amount of lysyl-AFBi 

























peak area of sample x concentration of standard in ng/ml 
peak area of standard 
= peak area of sample x 61.47ng/ml 
129.70 
concentration of sample in ng/ml in 1ml sample is equivalent to 3mg of digested albumin 
Toxins other than AFBi have also been shown to conjugate to proteins and DNA in the same 
way as AFBi (Gabriele and Wild, 1991) it will, therefore, be of interest to conduct further studies to 
find out the role of multimycotoxicosis in diseases conditions. Gqaleni (1996), has shown that 
between 7 and 15% cyclopiazonic acid conjugate to a carrier protein. Aflatoxin Gi has also been 
shown to conjugate to proteins. It will therefore, be of importance to set up an ELISA so as to 
validate HPLC results. The two techniques, used together, will ensure a high specificity to 
eliminate the risk of false positive results (Wild and Montesano, 1990). Moreover, an immunoassay 
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SUMMARY AND CONCLUSION 
Two objectives of this study were to develop a laboratory based method to detect the 
occurrence of AFBi-conjugates in humans and to use this to evaluate exposure of human subjects to 
AFBi. To achieve this, the following had to be developed:-
* Synthesis of lysyl-AFBi adduct for use as a standard. 
* Determine the reaction of selected Na-acetyl amino acids with aflatoxin Bi -epoxide in vitro. 
* Ion exchange chromatography clean-up of AFBi-lysine adduct. 
* The in vitro binding of arginine, histidine and lysine to AFBiO. 
* Thin layer chromatography methods for the detection of AFBi-macromolecular 
adducts. 
* The use of capillary electrophoresis in the detection of AFBi-macromolecular adduct 
detection. 
* High performance liquid UV detection of AFBi-lysine adduct. 
Having achieved the above, the method was applied to detect AFBi-lysine adducts in 
humans. All the samples that were analysed were found to have detectable level of AFBi-lysine 
adduct. It is evident, from this study, that some patients that attend at KEH have at some stage of 
their life history, been exposed to aflatoxins. Since some diseases are now thought to be 
multifactorial, e.g., kwashiorkor and liver cancer, it is possible that aflatoxicosis also plays a 
significant role in some of them. Most of the studies that are conducted, concentrate on the effects 
of individual mycotoxins, neglecting the multimycotoxicosis effect. 
Future Prospects 
Aflatoxicosis is not the only contributing factor to disease conditions of humans in South 
Africa. There are several other predominant mycotoxins, like Fusarium mycotoxins (Rava et ai, 
1996; Rava, 1996), which are of health concern. It is, therefore, important that more biomarkers be 
developed for such mycotoxins as fumonisins. In this way, a clear picture of multimycotoxicosis 
may be obtained. 
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APPENDIX la: DETECTION REAGENTS 
Spray reagents and solvents 
Tolidine spray reagent: For nitrogen containing compounds which can be converted into 
chloramines. O-tolidine (60 mg) are dissolved in 30 ml acetic acid, the solution diluted to 500 ml 
with distilled water and 1 g potassium iodide then added. N.B. o-tolidine is carcinogenic! 
Ninhydrin: For amino acids. Ninhydrin gives colours with the free amino-terminal groups 
of peptides; the epsilon-NFfc group of lysine residues produce a weak colour which appears slowly. 
Peptides with blocked N-termini (e.g., Na-acetyl peptides) are not detected with ninhydrin (except 
for a slow reaction with any epsilon-NH2 groups of lysine which may be present) and chlorination 
method is used for the detection of such peptides. 
Ninhydrin (0.2g) was in 100ml of 95% ethanol/acetic acid (20:1, v/v). The thin layer was 
dipped into or sprayed with this solution and dried at 60°C for 30 min. Colour development may 
alternatively take place at room temperature overnight. 
Ninhydrin-cadmium acetate chromogenic reagent: Cadmium acetate (0.5g) was 
dissolved in 50ml water to which 10ml glacial acetic acid had been added. Acetone was then added 
until the total volume is 500ml. Portions of that solution were taken before use and sufficient solid 
ninhydrin added until the final concentration is 0.2% (w/v). 
Dipping solutions for epoxides 
Dipping solution I: Depending on the amount that was needed, 9g 4-(4-
nitrobenzyl)pyridine (NBP) and 90mg butylhydroxytoluene (BHT) (this is 2,6 Di-tert-butyl-4-
methylphenol) were dissolved in 90ml chloroform. 
Dipping solution II: Depending on the amount that was needed, 24ml tetraethylene 
pentamine was dissolved in 60mg butylhydroxytoluene in 36ml dichloromethane. 
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APPENDIX lb: MEDIA 
Yeast extract sucrose (YES) medium 
The following ingredients were dissolved in a litre of distilled water and dispensed into 
media bottles and autoclaved at 115°C for 15 minutes: 
Yeast extract 20.0g 
Sucrose lOO.Og 
Agar O.lg 
Potato dexrose agar (PDA) 
Potato dexrose agar (39g) was suspended in IL of distilled water and boiled until it 
dissolved. The medium was then sterilized at 121°C for 15 minutes in the autoclave. 
APPENDIX lc: UV VISIBLE SPECTRA OF ADDUCTS 



















Isoberic points: 246(18 215); 282(11 046) and 379(12405). 
89 












Isoberic points: 287 and 334. 
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APPENDIX II 
SPECTROPHOTOMETRIC SCANS OF Na-ACETYL AMINO ACIDS AND THEIR EPOXIDE 
DERIVATIVES 
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